
文件下载
药用类麻醉药品目录(2025 年版)
表格
序号 | 中文名 | 英文名 | CAS号 | 备注 | 结构式 |
1 | 阿芬太尼 | Alfentanil | 71195-58-9 | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1 |
|
2 | 阿法罗定 | Alphaprodine | 77-20-3 | CCC(=O)OC1(C2=CC=CC=C2)CCN(C)CC1C |
|
3 | 阿尼利定 | Anileridine | 144-14-9 | CCOC(=O)C1(C2=CC=CC=C2)CCN(CCC2=CC=C(N)C=C2)CC1 |
|
4 | 布桂嗪* | Bucinnazine | CCCC(=O)N1CCN(C/C=C/C2=CC=CC=C2)CC1 |
||
5 | 可待因* | Codeine | 76-57-3 | COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@@]54CCN3C |
|
6 | 罂粟浓缩物* | Concentrate of Poppy Straw | 包括罂粟果提取物*,罂粟果提取物粉* | ||
7 | 地芬诺辛 | Difenoxin | 28782-42-5 | N#CC(CCN1CCC(C(=O)O)(C2=CC=CC=C2)CC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
8 | 双氢可待因* | Dihydrocodeine | 125-28-0 | COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5OC1=C2[C@@]54CCN3C |
|
9 | 二氢埃托啡* | Dihydroetorphine | 14357-76-7 | CCCC(C)(O)[C@H]1C[C@]23CC[C@]1(OC)[C@@H]1COC4=C5C(=CC=C4O)C[C@H]2N(C)CC[C@]513 |
|
10 | 地芬诺酯* | Diphenoxylate | 915-30-0 | CCOC(=O)C1(C2=CC=CC=C2)CCN(CCC(C#N)(C2=CC=CC=C2)C2=CC=CC=C2)CC1 |
|
11 | 羟蒂巴酚 | Drotebanol | 3176-03-2 | COC1=CC=C2C[C@H]3N(C)CC[C@@]4(C[C@H](O)CC[C@@]34O)C2=C1OC |
|
12 | 乙基吗啡* | Ethylmorphine | 76-58-4 | CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@@H](O)[C@@H]5OC1=C2[C@]45CCN3C |
|
13 | 芬太尼* | Fentanyl | 437-38-7 | CCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
|
14 | 氢可酮* | Hydrocodone | 125-29-1 | COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@@]54CCN3C |
|
15 | 氢吗啡酮* | Hydromorphone | 466-99-9 | CN1CC[C@]23C4=C5O[C@H]2C(=O)CC[C@H]3[C@H]1CC4=CC=C5O |
|
16 | 左啡诺 | Levorphanol | 77-07-6 | CN1CC[C@]23CCCC[C@H]2[C@H]1CC1=CC=C(O)C=C13 |
|
17 | 美沙酮* | Methadone | 76-99-3 | CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
18 | 吗啡* | Morphine | 57-27-2 | 包括吗啡阿托品注射液* | CN1CC[C@]23C4=C5O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1CC4=CC=C5O |
19 | 奥赛利定 | Oliceridine | 1401028-24-7 | TRV-130 | COC1=C(CNCC[C@@]2(C3=NC=CC=C3)CCOC3(CCCC3)C2)SC=C1 |
20 | 阿片* | Opium | 8008-60-4 | 包括复方樟脑酊*、阿桔片* | |
21 | 羟考酮* | Oxycodone | 76-42-5 | COC1=CC=C2C[C@H]3N(C)CC[C@]45C2=C1O[C@H]4C(=O)CC[C@@]35O |
|
22 | 羟吗啡酮 | Oxymorphone | 76-41-5 | CN1CC[C@]23C4=C5O[C@H]2C(=O)CC[C@@]3(O)[C@H]1CC4=CC=C5O |
|
23 | 哌替啶* | Pethidine | 57-42-1 | CCOC(=O)C1(C2=CC=CC=C2)CCN(C)CC1 |
|
24 | 福尔可定* | Pholcodine | 509-67-1 | CN1CC[C@]23C4=C5O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1CC4=CC=C5OCCN1CCOCC1 |
|
25 | 罂粟壳* | Poppy Shell | |||
26 | 消旋甲啡烷 | Racemethorphan | 510-53-2 | COC1=CC=C2CC3C4CCCCC4(CCN3C)C2=C1 |
|
27 | 消旋啡烷 | Racemorphan | 297-90-5 | CN1CC[C@]23CCCC[C@H]2[C@H]1CC1=CC=C(O)C=C13 |
|
28 | 瑞芬太尼* | Remifentanil | 132875-61-7 | CCC(=O)N(C1=CC=CC=C1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1 |
|
29 | 舒芬太尼* | Sufentanil | 56030-54-7 | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCC2=CC=CS2)CC1 |
|
30 | 泰吉利定 | Tegileridine | 2095345-66-5 | CCO[C@H]1CC[C@H](NCC[C@@]2(C3=CC=CC=N3)CCOC3(CCCC3)C2)C2=CC=CC=C21 |
|
31 | 蒂巴因* | Thebaine | 115-37-7 | COC1=CC=C2[C@H]3CC4=CC=C(OC)C5=C4[C@@]2(CCN3C)[C@H]1O5 |
|
32 | 替利定 | Tilidine | 20380-58-9 | CCOC(=O)[C@]1(C2=CC=CC=C2)CCC=C[C@H]1N(C)C |
注:1.上述品种包括其可能存在的盐和单方制剂(除非另有规定)。
2.上述品种包括其可能存在的立体异构体、酯及醚(除非另有规定)。
3.品种目录有*的麻醉药品为我国生产及使用的品种。
药用类精神药品目录(2025 年版)
第一类
表格
序号 | 中文名 | 英文名 | CAS号 | 备注 | 结构式 |
1 | 安非拉酮 | Amfepramone | 90-84-6 | CCN(CC)C(C)C(=O)C1=CC=CC=C1 |
|
2 | 苯丙胺 | Amfetamine | 300-62-9 | CC(N)CC1=CC=CC=C1 |
|
3 | 苄基哌嗪 | Benzylpiperazine | 2759-28-6 | BZP | C1=CC=C(CN2CCNCC2)C=C1 |
4 | 丁丙诺啡* | Buprenorphine | 52485-79-7 | CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(=C(O)C=C4)O[C@@H]2[C@]53CCN1CC1CC1 |
|
5 | 右苯丙胺 | Dexamfetamine | 51-64-9 | C[C@H](N)CC1=CC=CC=C1 |
|
6 | γ-羟丁酸* | Gamma-hydroxybutyrate | 591-81-1 | GHB | O=C(O)CCCO |
7 | 氯胺酮* | Ketamine | 6740-88-1 | CNC1(C2=C(Cl)C=CC=C2)CCCCC1=O |
|
8 | 左苯丙胺 | Levamfetamine | 156-34-3 | C[C@@H](N)CC1=CC=CC=C1 |
|
9 | 马吲哚* | Mazindol | 22232-71-9 | OC1(C2=CC=C(Cl)C=C2)C2=C(C=CC=C2)C2=NCCN21 |
|
10 | 甲喹酮 | Methaqualone | 72-44-6 | CC1=C(N2C(C)=NC3=C(C=CC=C3)C2=O)C=CC=C1 |
|
11 | 哌醋甲酯* | Methylphenidate | 113-45-1 | COC(=O)C(C1=CC=CC=C1)C1CCCCN1 |
|
12 | 咪达唑仑原料药及注射剂* | Midazolam API and Injection | |||
13 | 司可巴比妥* | Secobarbital | 76-73-3 | C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O |
|
14 | 他喷他多 | Tapentadol | 175591-23-8 | CC[C@@H](C1=CC=CC(O)=C1)[C@@H](C)CN(C)C |
|
15 | 三唑仑* | Triazolam | 28911-01-5 | CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C3=CC(Cl)=CC=C3N12 |
|
16 | 齐培丙醇 | Zipeprol | 34758-83-3 | COC(CN1CCN(CC(O)C(OC)C2=CC=CC=C2)CC1)C1=CC=CC=C1 |
|
17 | 含氢可酮复方口服固体制剂* | 每剂量单位含氢可酮碱大于 5 毫克,且不含其它麻醉药品、精神药品或药品类易制毒化学品的复方口服固体制剂 | |||
18 | 含羟考酮复方口服固体制剂* | 每剂量单位含羟考酮碱不超过 5 毫克,且不含其它麻醉药品、精神药品或药品类易制毒化学品的复方口服固体制剂 |
第二类
表格
序号 | 中文名 | 英文名 | CAS号 | 备注 | 结构式 |
1 | 阿洛巴比妥 | Allobarbital | 52-43-7 | C=CCC1(C(=O)NC(=O)NC1=O)CC=C |
|
2 | 阿普唑仑* | Alprazolam | 28981-97-7 | CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12 |
|
3 | 异戊巴比妥* | Amobarbital | 57-43-2 | CCC1(CCC(C)C)C(=O)NC(=O)NC1=O |
|
4 | 巴比妥* | Barbital | 57-44-3 | CCC1(CC)C(=O)NC(=O)NC1=O |
|
5 | 溴西泮 | Bromazepam | 1812-30-2 | O=C1CN=C(C2=NC=CC=C2)C2=CC(Br)=CC=C2N1 |
|
6 | 溴替唑仑 | Brotizolam | 57801-81-7 | O=C1CN=C(C2=NC=CC=C2)C2=CC(Br)=CC=C2N1 |
|
7 | 丁丙诺啡透皮贴剂* | Buprenorphine Transdermal patch | |||
8 | 布他比妥 | Butalbital | 77-26-9 | C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O |
|
9 | 布托啡诺* | Butorphanol | 42408-82-2 | OC1=CC2=C(C=C1)C[C@H]1N(CC3CCC3)CC[C@@]23CCCC[C@@]13O |
|
10 | 咖啡因* | Caffeine | 58-08-2 | CN1C(=O)C2=C(N=CN2C)N(C)C1=O |
|
11 | 安钠咖* | Caffeine Sodium Benzoate | CNB | CN1C(=O)C2=C(N=CN2C)N(C)C1=O.[Na+].O=C([O-])C1=CC=CC=C1 |
|
12 | 卡立普多 | Carisoprodol | 78-44-4 | CCCC(C)(COC(=O)N)COC(=O)NC(C)C |
|
13 | 去甲伪麻黄碱 | Cathine | 492-39-7 | C[C@H](N)[C@@H](O)C1=CC=CC=C1 |
|
14 | 西博帕多 | Cebranopadol | 863513-91-1 | CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5 |
|
15 | 氯氮䓬 | Chlordiazepoxide | 58-25-3 | C/N=C1/CN(O)C(C2=CC=CC=C2)=C2C=C(Cl)C=CC2=N1 |
|
16 | 氯巴占 | Clobazam | 22316-47-8 | CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=CC(Cl)=CC=C21 |
|
17 | 氯硝西泮* | Clonazepam | 1622-61-3 | O=C1CN=C(C2=C(Cl)C=CC=C2)C2=CC([N+](=O)[O-])=CC=C2N1 |
|
18 | 氯噻西泮 | Clotiazepam | 33671-46-4 | CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=C(Cl)C=CC=C1 |
|
19 | 氯噁唑仑 | Cloxazolam | 24166-13-0 | O=C1CN2CCOC2(C2=C(Cl)C=CC=C2)C2=CC(Cl)=CC=C2N1 |
|
20 | 地洛西泮 | Delorazepam | 2894-67-9 | O=C1CN=C(C2=C(Cl)C=CC=C2)C2=CC(Cl)=CC=C2N1 |
|
21 | 右旋芬氟拉明 | Dexfenfluramine | 3239-44-9 | CCN[C@@H](C)CC1=CC=CC(C(F)(F)F)=C1 |
|
22 | 右美沙芬 | Dextromethorphan | 125-71-3 | COC1=CC=C2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)C2=C1 |
|
23 | 地佐辛及其注射剂* | Dezocine and Its Injection | 53648-55-8 | C[C@@]12CCCCC[C@@H](CC3=CC=C(O)C=C31)[C@@H]2N |
|
24 | 地西泮* | Diazepam | 439-14-5 | 安定 | CN1C(=O)CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21 |
25 | 地达西尼 | Dimdazenil | 308239-86-3 | CN(C)CC1=NC(C2=C3CN(C)C(=O)C4=C(Cl)C=CC=C4N3C=N2)=NO1 |
|
26 | 依他佐辛 | Eptazocine | 72522-13-5 | CN1CC[C@]2(C)CC(CC3=C2C=C(O)C=C3)C1 |
|
27 | 麦角胺咖啡因片* | Ergotamine and Caffeine Tablet | CN1CC(C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4)C[C@H]21.CN1CC(C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](CC4=CC=CC=C4)N3C2=O)C=C2C3=CC=CC4=C3C(=CN4)C[C@H]21.O=C(O)[C@H](O)[C@@H](O)C(=O)O |
||
28 | 艾司唑仑* | Estazolam | 29975-16-4 | ClC1=CC=C2C(=C1)C(C1=CC=CC=C1)=NCC1=NN=CN21 |
|
29 | 氯氟䓬乙酯 | Ethyl Loflazepate | 29177-84-2 | CCOC(=O)C1N=C(C2=C(F)C=CC=C2)C2=CC(Cl)=CC=C2NC1=O |
|
30 | 依替唑仑 | 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | 40054-69-1 | Etizolam | CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=C(Cl)C=CC=C1 |
31 | 依托咪酯 | etomidate | 33125-97-2 | 在中国境内批准上市的含依托咪酯的药品制剂除外 | CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 |
32 | 芬氟拉明 | Fenfluramine | 458-24-2 | CCNC(C)CC1=CC(=CC=C1)C(F)(F)F |
|
33 | 氟地西泮 | Fludiazepam | 3900-31-0 | CN1C(=O)CN=C(C2=C(F)C=CC=C2)C2=CC(Cl)=CC=C21 |
|
34 | 氟硝西泮 | Flunitrazepam | 1622-62-4 | CN1C(=O)CN=C(C2=C(F)C=CC=C2)C2=CC([N+](=O)[O-])=CC=C21 |
|
35 | 氟西泮* | Flurazepam | 17617-23-1 | CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C2=CC(Cl)=CC=C21 |
|
36 | 格鲁米特* | Glutethimide | 77-21-4 | CCC1(C2=CC=CC=C2)CCC(=O)NC1=O |
|
37 | 卤沙唑仑 | Haloxazolam | 59128-97-1 | O=C1CN2CCOC2(C2=C(F)C=CC=C2)C2=CC(Br)=CC=C2N1 |
|
38 | 氯普唑仑 | Loprazolam | 61197-73-7 | CN1CCN(/C=C2\N=C3CN=C(C4=CC=CC=C4Cl)C4=CC([N+](=O)[O-])=CC=C4N3C2=O)CC1 |
|
39 | 劳拉西泮* | Lorazepam | 846-49-1 | O=C1NC2=CC=C(Cl)C=C2C(C2=C(Cl)C=CC=C2)=NC1O |
|
40 | 氯卡色林 | Lorcaserin | 616202-92-7 | C[C@H]1CNCCC2=C1C=C(Cl)C=C2 |
|
41 | 氯甲西泮 | Lormetazepam | 848-75-9 | CN1C(=O)C(O)N=C(C2=C(Cl)C=CC=C2)C2=CC(Cl)=CC=C21 |
|
42 | 美达西泮 | Medazepam | 2898-12-6 | CN1CCN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21 |
|
43 | 甲丙氨酯* | Meprobamate | 57-53-4 | CCCC(C)(COC(N)=O)COC(N)=O |
|
44 | 甲苯巴比妥 | Methylphenobarbital | 115-38-8 | CCC1(C2=CC=CC=C2)C(=O)NC(=O)N(C)C1=O |
|
45 | 咪达唑仑* | Midazolam | 59467-70-8 | 原料药及注射剂除外 | CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C3=CC(Cl)=CC=C3N21 |
46 | 莫达非尼 | Modafinil | 68693-11-8 | NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1 |
|
47 | 纳布啡及其注射剂 | Nalbuphine and its injection | 20594-83-6 | OC1=CC=C2C[C@H]3N(CC4CCC4)CC[C@]45C2=C1O[C@H]4[C@@H](O)CC[C@@]35O |
|
48 | 纳呋拉啡 | Nalfurafine | 152657-84-6 | CN(C(=O)/C=C/C1=COC=C1)[C@@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CC2)[C@H]1O5 |
|
49 | 尼美西泮 | Nimetazepam | 2011-67-8 | CN1C(=O)CN=C(C2=CC=CC=C2)C2=CC([N+](=O)[O-])=CC=C21 |
|
50 | 硝西泮* | Nitrazepam | 146-22-5 | O=C1CN=C(C2=CC=CC=C2)C2=CC([N+](=O)[O-])=CC=C2N1 |
|
51 | 去甲西泮 | Nordazepam | 1088-11-5 | O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1 |
|
52 | 奥沙西泮* | Oxazepam | 604-75-1 | CC1CN2CC(=O)NC3=CC=C(Cl)C=C3C2(C2=CC=CC=C2)O1 |
|
53 | 奥沙唑仑 | Oxazolam | 24143-17-7 | O=C1NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1O |
|
54 | 喷他佐辛* | Pentazocine | 359-83-1 | C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O |
|
55 | 戊巴比妥* | Pentobarbital | 76-74-4 | CCCC(C)C1(CC)C(=O)NC(=O)NC1=O |
|
56 | 吡仑帕奈 | Perampanel | 380917-97-5 | N#CC1=C(C2=CC(C3=CC=CC=N3)=CN(C3=CC=CC=C3)C2=O)C=CC=C1 |
|
57 | 苯甲曲秦 | Phendimetrazine | 634-03-7 | C[C@H]1[C@H](C2=CC=CC=C2)OCCN1C |
|
58 | 苯巴比妥* | Phenobarbital | 50-06-6 | CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O |
|
59 | 芬特明 | Phentermine | 122-09-8 | CC(C)(N)CC1=CC=CC=C1 |
|
60 | 匹那西泮 | Pinazepam | 52463-83-9 | C#CCN1C(=O)CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21 |
|
61 | 哌苯甲醇 | Pipradrol | 467-60-7 | OC(C1=CC=CC=C1)(C1=CC=CC=C1)C1CCCCN1 |
|
62 | 普拉西泮 | Prazepam | 2955-38-6 | O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1CC1CC1 |
|
63 | 瑞马唑仑 | Dimdazenil | 308242-62-8 | CC1=CN=C2N1C3=C(C=C(C=C3)Br)C(=N[C@H]2CCC(=O)OC)C4=CC=CC=N4 |
|
64 | 仲丁比妥 | Secbutabarbital | 125-40-6 | CCC(C)C1(CC)C(=O)NC(=O)NC1=O |
|
65 | 丝右哌甲酯 | Serdexmethylphenidate | 1996626-29-9 | COC(=O)[C@@H]([C@H]1CCCCN1C(=O)OC[N+]2=CC=CC(=C2)C(=O)N[C@@H](CO)C(=O)[O-])C3=CC=CC=C3 |
|
66 | 替马西泮 | Temazepam | 846-50-4 | CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21 |
|
67 | 四氢西泮 | Tetrazepam | 10379-14-3 | CN1C(=O)CN=C(C2=CCCCC2)C2=CC(Cl)=CC=C21 |
|
68 | 曲马多* | Tramadol | 27203-92-5 | 包括含曲马多复方制剂 | COC1=CC=CC([C@@]2(O)CCCC[C@@H]2CN(C)C)=C1 |
69 | 韦利西贝 | Valiloxybate | 238401-16-6 | CC(C)[C@@H](C(=O)OCCCC(=O)O)N |
|
70 | 扎来普隆* | Zaleplon | 151319-34-5 | CCN(C(C)=O)C1=CC(C2=CC=NC3=C(C#N)C=NN23)=CC=C1 |
|
65 | 唑吡坦 | Zolpidem | 82626-48-0 | CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1 |
|
72 | 佐匹克隆 | Zopiclone | 43200-80-2 | CN1CCN(C(=O)OC2C3=C(N=CC=N3)C(=O)N2C2=CC=C(Cl)C=N2)CC1 |
|
73 | 舒拉诺龙 | Zuranolone | 1632051-40-1 | C[C@]1(CC[C@H]2[C@@H](C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CN5C=C(C=N5)C#N)C)O |
|
74 | 丁丙诺啡和纳洛酮复方口服固体制剂 | ||||
75 | 含可待因复方口服液体制剂* | 包括口服溶液剂、糖浆剂 | |||
76 | 含地芬诺酯复方制剂* | ||||
77 | 含氢可酮复方口服固体制剂* | 每剂量单位含氢可酮碱不超过5毫克,且不含其它麻醉药品、精神药品或药品类易制毒化学品的复方口服固体制剂 | |||
78 | 含羟考酮复方口服固体制剂* | 每剂量单位含羟考酮碱不超过5毫克,且不含其它麻醉药品、精神药品或药品类易制毒化学品的复方口服固体制剂 |
注:1.上述品种包括其可能存在的盐和单方制剂(除非另有规定)。
2.上述品种包括其可能存在的立体异构体(除非另有规定)。
3.品种目录有*的麻醉药品为我国生产及使用的品种。
非药用类麻醉药品和精神药品目录(2025 年版)
表格
序号 | 中文名 | 英文名 | CAS号 | 备注 | 结构式 |
1 | N-(2-甲氧基苄基)-2-(2,5-二甲氧基-4-溴苯基)乙胺 | 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 1026511-90-9 | 2C-B-NBOMe | COC1=CC(CCNCC2=C(OC)C=CC=C2)=C(OC)C=C1Br |
2 | 2,5-二甲氧基-4-氯苯乙胺 | 4-Chloro-2,5-dimethoxyphenethylamine | 88441-14-9 | 2C-C | COC1=CC(CCN)=C(OC)C=C1Cl |
3 | N-(2-甲氧基苄基)-2-(2,5-二甲氧基-4-氯苯基)乙胺 | 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 1227608-02-7 | 2C-C-NBOMe | COC1=CC(CCNCC2=C(OC)C=CC=C2)=C(OC)C=C1Cl |
4 | 2,5-二甲氧基-4-甲基苯乙胺 | 4-Methyl-2,5-dimethoxyphenethylamine | 24333-19-5 | 2C-D | COC1=CC(CCN)=C(OC)C=C1C |
5 | N-(2-甲氧基苄基)-2-(2,5-二甲氧基-4-甲基苯基)乙胺 | 2-(4-Methyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 1354632-02-2 | 2C-D-NBOMe | COC1=CC(CCNCC2=C(OC)C=CC=C2)=C(OC)C=C1C |
6 | 2,5-二甲氧基-4-乙基苯乙胺 | 4-Ethyl-2,5-dimethoxyphenethylamine | 71539-34-9 | 2C-E | CCC1=CC(OC)=C(CCN)C=C1OC |
7 | N-(2-甲氧基苄基)-2-(2,5-二甲氧基-4-碘苯基)乙胺 | 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine | 919797-19-6 | 2C-I-NBOMe | COC1=CC(CCNCC2=C(OC)C=CC=C2)=C(OC)C=C1I |
8 | 2,5-二甲氧基-4-丙基苯乙胺 | 4-Propyl-2,5-dimethoxyphenethylamine | 207740-22-5 | 2C-P | CCCC1=C(OC)C=C(CCN)C(OC)=C1 |
9 | 2,5-二甲氧基-4-乙硫基苯乙胺 | 4-Ethylthio-2,5-dimethoxyphenethylamine | 207740-24-7 | 2C-T-2 | CCSC1=CC(OC)=C(CCN)C=C1OC |
10 | 2,5-二甲氧基-4-异丙基硫基苯乙胺 | 4-Isopropylthio-2,5-dimethoxyphenethylamine | 207740-25-8 | 2C-T-4 | COC1=C(CCN)C=C(OC)C(SC(C)C)=C1 |
11 | 2,5-二甲氧基-4-丙硫基苯乙胺 | 4-Propylthio-2,5-dimethox-phenethylamine | 207740-26-9 | 2C-T-7 | CCCSC1=CC(OC)=C(CCN)C=C1OC |
12 | 2-氟苯丙胺 | 1-(2-Fluorophenyl)propan-2-amine | 1716-60-5 | 2-FA | CC(N)CC1=C(F)C=CC=C1 |
13 | 2-氟甲基苯丙胺 | N-Methyl-1-(2-fluorophenyl)propan-2-amine | 1017176-48-5 | 2-FMA | CNC(C)CC1=C(F)C=CC=C1 |
14 | 1-(2-苯并呋喃基)-N-甲基-2-丙胺 | N-Methyl-1-(benzofuran-2-yl)propan-2-amine | 806596-15-6 | 2-MAPB | CNC(C)CC1=CC2=C(C=CC=C2)O1 |
15 | 3-氟苯丙胺 | 1-(3-Fluorophenyl)propan-2-amine | 1626-71-7 | 3-FA | CC(N)CC1=CC=CC(F)=C1 |
16 | 3-氟甲基苯丙胺 | N-Methyl-1-(3-fluorophenyl)propan-2-amine | 1182818-14-9 | 3-FMA | CNC(C)CC1=CC=CC(F)=C1 |
17 | 4-氯苯丙胺 | 1-(4-Chlorophenyl)propan-2-amine | 64-12-0 | 4-CA | CC(N)CC1=CC=C(Cl)C=C1 |
18 | 4-氟苯丙胺 | 1-(4-Fluorophenyl)propan-2-amine | 459-02-9 | 4-FA | CC(N)CC1=CC=C(F)C=C1 |
19 | 4-氟甲基苯丙胺 | N-Methyl-1-(4-fluorophenyl)propan-2-amine | 351-03-1 | 4-FMA | CNC(C)CC1=CC=C(F)C=C1 |
20 | 1-[5-(2,3-二氢苯并呋喃基)]-2-丙胺 | 1-(2,3-Dihydro-1-benzofuran-5-yl)propan-2-amine | 152624-03-8 | 5-APDB | CC(N)CC1=CC=C2OCCC2=C1 |
21 | 1-(5-苯并呋喃基)-N-甲基-2-丙胺 | N-Methyl-1-(benzofuran-5-yl)propan-2-amine | 1354631-77-8 | 5-MAPB | CNC(C)CC1=CC=C2OC=CC2=C1 |
22 | 6-溴-3,4-亚甲二氧基甲基苯丙胺 | N-Methyl-(6-bromo-3,4-methylenedioxyphenyl)propan-2-amine | 2170110-34-4 | 6-Br-MDMA | CNC(C)CC1=C(Br)C=C2OCOC2=C1 |
23 | 6-氯-3,4-亚甲二氧基甲基苯丙胺 | N-Methyl-(6-chloro-3,4-methylenedioxyphenyl)propan-2-amine | 319920-71-3 | 6-Cl-MDMA | CNC(C)CC1=C(Cl)C=C2OCOC2=C1 |
24 | 1-(2,5-二甲氧基-4-氯苯基)-2-丙胺 | 1-(4-Chloro-2,5-dimethoxyphenyl)propan-2-amine | 123431-31-2 | DOC | COC1=CC(CC(C)N)=C(OC)C=C1Cl |
25 | 1-(2-噻吩基)-N-甲基-2-丙胺 | N-Methyl-1-(thiophen-2-yl)propan-2-amine | 801156-47-8 | MPA | CNC(C)CC1=CC=CS1 |
26 | N-(1-氨甲酰基-2-甲基丙基)-1-(5-氟戊基)吲哚-3-甲酰胺 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 1801338-26-0 | 5F-ABICA | CC(C)[C@H](NC(=O)C1=CN(CCCCCF)C2=C1C=CC=C2)C(N)=O |
27 | N-(1-氨甲酰基-2-甲基丙基)-1-(5-氟戊基)吲唑-3-甲酰胺 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | 1800101-60-3 | 5F-AB-PINACA | CC(C)[C@@H](C(=O)N)NC(=O)C1=NN(C2=CC=CC=C21)CCCCCF |
28 | N-(1-氨甲酰基-2,2-二甲基丙基)-1-(5-氟戊基)吲哚-3-甲酰胺 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 1801338-27-1 | 5F-ADBICA | CC(C)[C@H](NC(=O)C1=NN(CCCCCF)C2=C1C=CC=C2)C(N)=O |
29 | N-(1-甲氧基羰基-2-甲基丙基)-1-(5-氟戊基)吲唑-3-甲酰胺 | 1-Methoxy-3-methyl-1-oxobutan-2-yl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | 1715016-74-2 | 5F-AMB | CC(C)(C)[C@H](NC(=O)C1=CN(CCCCCF)C2=C1C=CC=C2)C(N)=O |
30 | N-(1-金刚烷基)-1-(5-氟戊基)吲唑-3-甲酰胺 | N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | 1400742-13-3 | 5F-APINACA | COC(=O)C(NC(=O)C1=NN(CCCCCF)C2=C1C=CC=C2)C(C)C |
31 | 1-(5-氟戊基)吲哚-3-甲酸-8-喹啉酯 | Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate | 1400742-41-7 | 5F-PB-22 | O=C(NC12CC3CC(CC(C3)C1)C2)C1=NN(CCCCCF)C2=C1C=CC=C2 |
32 | 1-(5-氟戊基)-3-(2,2,3,3-四甲基环丙甲酰基)吲哚 | (1-(5-Fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 1364933-54-9 | 5F-UR-144 | O=C(OC1=C2N=CC=CC2=CC=C1)C1=CN(CCCCCF)C2=C1C=CC=C2 |
33 | 1-[2-(N-吗啉基)乙基]-3-(2,2,3,3-四甲基环丙甲酰基)吲哚 | (1-(2-Morpholin-4-ylethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 895155-26-7 | A-796,260 | CC1(C)C(C(=O)C2=CN(CCCCCF)C3=C2C=CC=C3)C1(C)C |
34 | 1-(4-四氢吡喃基甲基)-3-(2,2,3,3-四甲基环丙甲酰基)吲哚 | (1-(Tetrahydropyran-4-ylmethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 895155-57-4 | A-834,735 | CC1(C)C(C(=O)C2=CN(CCN3CCOCC3)C3=C2C=CC=C3)C1(C)C |
35 | N-(1-氨甲酰基-2-甲基丙基)-1-(环己基甲基)吲唑-3-甲酰胺 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | 1185887-21-1 | AB-CHMINACA | CC1(C)C(C(=O)C2=CN(CC3CCOCC3)C3=C2C=CC=C3)C1(C)C |
36 | N-(1-氨甲酰基-2-甲基丙基)-1-(4-氟苄基)吲唑-3-甲酰胺 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | 1629062-56-1 | AB-FUBINACA | CC(C)[C@H](NC(=O)C1=NN(CC2CCCCC2)C2=C1C=CC=C2)C(N)=O |
37 | N-(1-氨甲酰基-2-甲基丙基)-1-戊基吲唑-3-甲酰胺 | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | 1445583-20-9 | AB-PINACA | CC(C)C(NC(=O)C1=NN(CC2=CC=C(F)C=C2)C2=C1C=CC=C2)C(N)=O |
38 | N-(1-氨甲酰基-2,2-二甲基丙基)-1-戊基吲哚-3-甲酰胺 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide | 1445583-48-1 | ADBICA | CCCCCN1N=C(C(=O)NC(C(N)=O)C(C)C)C2=C1C=CC=C2 |
39 | N-(1-氨甲酰基-2,2-二甲基丙基)-1-戊基吲唑-3-甲酰胺 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | 1633766-73-0 | ADB-PINACA | CCCCCN1C=C(C(=O)NC(C(N)=O)C(C)(C)C)C2=C1C=CC=C2 |
40 | 1-[(N-甲基-2-哌啶基)甲基]-3-(1-萘甲酰基)吲哚 | (1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 137642-54-7 | AM-1220 | CN1CCCCC1CN1C=C(C(=O)C2=CC=CC3=C2C=CC=C3)C2=C1C=CC=C2 |
41 | 1-[(N-甲基-2-哌啶基)甲基]-3-(1-金刚烷基甲酰基)吲哚 | (1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(adamantan-1-yl)methanone | 335160-66-2 | AM-1248 | CN1CCCCC1CN1C=C(C(=O)C23CC4CC(CC(C4)C2)C3)C2=C1C=CC=C2 |
42 | 1-[(N-甲基-2-哌啶基)甲基]-3-(2-碘苯甲酰基)吲哚 | (1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(2-iodophenyl)methanone | 444912-75-8 | AM-2233 | CN1CCCCC1CN1C=C(C(=O)C2=C(I)C=CC=C2)C2=C1C=CC=C2 |
43 | N-(1-金刚烷基)-1-戊基吲哚-3-甲酰胺 | N-(1-Adamantyl)-1-pentyl-1H-indole-3-carboxamide | 1345973-50-3 | APICA | CCCCCN1C=C(C(=O)NC23CC4CC(CC(C4)C2)C3)C2=C1C=CC=C2 |
44 | N-(1-金刚烷基)-1-戊基吲唑-3-甲酰胺 | N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide | 1345973-53-6 | APINACA | CCCCCN1N=C(C(=O)NC23CC4CC(CC(C4)C2)C3)C2=C1C=CC=C2 |
45 | 1-(1-萘甲酰基)-4-戊氧基萘 | (4-Pentyloxynaphthalen-1-yl)(naphthalen-1-yl)methanone | 432047-72-8 | CB-13 | CCCCCOC1=C2C=CC=CC2=C(C(=O)C2=C3C=CC=CC3=CC=C2)C=C1 |
46 | N-(1-甲基-1-苯基乙基)-1-(4-四氢吡喃基甲基)吲唑-3-甲酰胺 | N-(2-Phenylpropan-2-yl)-1-(tetrahydropyran-4-ylmethyl)-1H-indazole-3-carboxamide | 1400742-50-8 | CUMYL-THPINACA | CC(C)(NC(=O)C1=NN(CC2CCOCC2)C2=CC=CC=C12)C1=CC=CC=C1 |
47 | 1-(5-氟戊基)-3-(4-乙基-1-萘甲酰基)吲哚 | (1-(5-Fluoropentyl)-1H-indol-3-yl)(4-ethylnaphthalen-1-yl)methanone | 1364933-60-7 | EAM-2201 | CCC1=C2C=CC=CC2=C(C(=O)C2=CN(CCCCCF)C3=C2C=CC=C3)C=C1 |
48 | 1-(4-氟苄基)-3-(1-萘甲酰基)吲哚 | (1-(4-Fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 2365471-45-8 | FUB-JWH-018 | O=C(C1=C2C=CC=CC2=CC=C1)C1=CN(CC2=CC=C(F)C=C2)C2=C1C=CC=C2 |
49 | 1-(4-氟苄基)吲哚-3-甲酸-8-喹啉酯 | Quinolin-8-yl1-(4-fluorobenzyl)-1H-indole-3-carboxylate | 1800098-36-5 | FUB-PB-22 | O=C(OC1=C2N=CC=CC2=CC=C1)C1=CN(CC2=CC=C(F)C=C2)C2=C1C=CC=C2 |
50 | 2-甲基-1-戊基-3-(1-萘甲酰基)吲哚 | (2-Methyl-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 155471-10-6 | JWH-007 | CCCCCN1C(C)=C(C(=O)C2=CC=CC3=C2C=CC=C3)C2=C1C=CC=C2 |
51 | 2-甲基-1-丙基-3-(1-萘甲酰基)吲哚 | (2-Methyl-1-propyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 155471-08-2 | JWH-015 | CCCN1C(=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=CC=CC=C43)C |
52 | 1-己基-3-(1-萘甲酰基)吲哚 | (1-Hexyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 209414-08-4 | JWH-019 | CCCCCCN1C=C(C(=O)C2=CC=CC3=C2C=CC=C3)C2=C1C=CC=C2 |
53 | 1-戊基-3-(4-甲氧基-1-萘甲酰基)吲哚 | (1-Pentyl-1H-indol-3-yl)(4-methoxynaphthalen-1-yl)methanone | 210179-46-7 | JWH-081 | CCCCCN1C=C(C(=O)C2=C3C=CC=CC3=C(OC)C=C2)C2=C1C=CC=C2 |
54 | 1-戊基-3-(4-甲基-1-萘甲酰基)吲哚 | (1-Pentyl-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone | 619294-47-2 | JWH-122 | CCCCCN1C=C(C(=O)C2=C3C=CC=CC3=C(C)C=C2)C2=C1C=CC=C2 |
55 | 1-戊基-3-(2-氯苯乙酰基)吲哚 | 2-(2-Chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone | 864445-54-5 | JWH-203 | CCCCCN1C=C(C(=O)CC2=C(Cl)C=CC=C2)C2=C1C=CC=C2 |
56 | 1-戊基-3-(4-乙基-1-萘甲酰基)吲哚 | (1-Pentyl-1H-indol-3-yl)(4-ethylnaphthalen-1-yl)methanone | 824959-81-1 | JWH-210 | CCCCCN1C=C(C(=O)C2=C3C=CC=CC3=C(CC)C=C2)C2=C1C=CC=C2 |
57 | 1-戊基-2-(2-甲基苯基)-4-(1-萘甲酰基)吡咯 | (5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone | 914458-22-3 | JWH-370 | CCCCCN1C=C(C(=O)C2=C3C=CC=CC3=CC=C2)C=C1C1=C(C)C=CC=C1 |
58 | 1-(5-氟戊基)-3-(4-甲基-1-萘甲酰基)吲哚 | (1-(5-Fluoropentyl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone | 1354631-24-5 | MAM-2201 | CC1=C2C=CC=CC2=C(C(=O)C2=CN(CCCCCF)C3=C2C=CC=C3)C=C1 |
59 | N-(1-甲氧基羰基-2,2-二甲基丙基)-1-(环己基甲基)吲哚-3-甲酰胺 | N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indole-3-carboxamide | 1715016-78-6 | MDMB-CHMICA | COC(=O)C(NC(=O)C1=NN(CC2CCCCC2)C2=C1C=CC=C2)C(C)(C)C |
60 | N-(1-甲氧基羰基-2,2-二甲基丙基)-1-(4-氟苄基)吲唑-3-甲酰胺 | N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | 1715016-77-5 | MDMB-FUBINACA | COC(=O)[C@H](NC(=O)C1=NN(CC2=CC=C(F)C=C2)C2=C1C=CC=C2)C(C)(C)C |
61 | 1-戊基吲哚-3-甲酸-8-喹啉酯 | Quinolin-8-yl1-pentyl-1H-indole-3-carboxylate | 1400742-17-7 | PB-22 | CCCCCN1C=C(C(=O)OC2=C3N=CC=CC3=CC=C2)C2=C1C=CC=C2 |
62 | N-(1-氨甲酰基-2-苯基乙基)-1-(5-氟戊基)吲唑-3-甲酰胺 | N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | 2205029-76-9 | PX-2 | NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=NN(CCCCCF)C2=C1C=CC=C2 |
63 | 1-戊基-3-(4-甲氧基苯甲酰基)吲哚 | (1-Pentyl-1H-indol-3-yl)(4-methoxyphenyl)methanone | 1345966-78-0 | RCS-4 | CCCCCN1C=C(C(=O)C2=CC=C(OC)C=C2)C2=C1C=CC=C2 |
64 | N-(1-金刚烷基)-1-(5-氟戊基)吲哚-3-甲酰胺 | N-(1-Adamantyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 1354631-26-7 | STS-135 | O=C(NC12CC3CC(CC(C3)C1)C2)C1=CN(CCCCCF)C2=CC=CC=C12 |
65 | 1-戊基-3-(2,2,3,3-四甲基环丙甲酰基)吲哚 | (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 1199943-44-6 | UR-144 | CCCCCN1C=C(C(=O)C2C(C)(C)C2(C)C)C2=C1C=CC=C2 |
66 | 2-氟甲卡西酮 | 1-(2-Fluorophenyl)-2-methylaminopropan-1-one | 1186137-35-8 | 2-FMC | CNC(C)C(=O)C1=C(F)C=CC=C1 |
67 | 2-甲基甲卡西酮 | 1-(2-Methylphenyl)-2-methylaminopropan-1-one | 1246911-71-6 | 2-MMC | CNC(C)C(=O)C1=C(C)C=CC=C1 |
68 | 3,4-二甲基甲卡西酮 | 1-(3,4-Dimethylphenyl)-2-methylaminopropan-1-one | 1082110-00-6 | 3,4-DMMC | CNC(C)C(=O)C1=CC=C(C)C(C)=C1 |
69 | 3-氯甲卡西酮 | 1-(3-Chlorophenyl)-2-methylaminopropan-1-one | 1049677-59-9 | 3-CMC | CNC(C)C(=O)C1=CC=CC(Cl)=C1 |
70 | 3-甲氧基甲卡西酮 | 1-(3-Methoxyphenyl)-2-methylaminopropan-1-one | 882302-56-9 | 3-MeOMC | CNC(C)C(=O)C1=CC=CC(OC)=C1 |
71 | 3-甲基甲卡西酮 | 1-(3-Methylphenyl)-2-methylaminopropan-1-one | 1246911-86-3 | 3-MMC | CNC(C)C(=O)C1=CC(C)=CC=C1 |
72 | 4-溴甲卡西酮 | 1-(4-Bromophenyl)-2-methylaminopropan-1-one | 486459-03-4 | 4-BMC | CNC(C)C(=O)C1=CC=C(Br)C=C1 |
73 | 4-氯甲卡西酮 | 1-(4-Chlorophenyl)-2-methylaminopropan-1-one | 1225843-86-6 | 4-CMC | CNC(C)C(=O)C1=CC=C(Cl)C=C1 |
74 | 4-氟甲卡西酮 | 1-(4-Fluorophenyl)-2-methylaminopropan-1-one | 447-40-5 | 4-FMC | CNC(C)C(=O)C1=CC=C(F)C=C1 |
75 | 1-(4-氟苯基)-2-(N-吡咯烷基)-1-戊酮 | 1-(4-Fluorophenyl)-2-(1-pyrrolidinyl)pentan-1-one | 850352-62-4 | 4-F-α-PVP | CCCC(C(=O)C1=CC=C(F)C=C1)N1CCCC1 |
76 | 1-(4-甲基苯基)-2-甲氨基-1-丁酮 | 1-(4-Methylphenyl)-2-methylaminobutan-1-one | 1337016-51-9 | 4-MeBP | CCC(NC)C(=O)C1=CC=C(C)C=C1 |
77 | 1-(4-甲氧基苯基)-2-(N-吡咯烷基)-1-戊酮 | 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)pentan-1-one | 14979-97-6 | 4-MeO-α-PVP | CCCC(C(=O)C1=CC=C(OC)C=C1)N1CCCC1 |
78 | 1-苯基-2-甲氨基-1-丁酮 | 1-Phenyl-2-methylaminobutan-1-one | 408332-79-6 | Buphedrone | CCC(NC)C(=O)C1=CC=CC=C1 |
79 | 2-甲氨基-1-[3,4-(亚甲二氧基)苯基]-1-丁酮 | 1-(3,4-Methylenedioxyphenyl)-2-methylaminobutan-1-one | 802575-11-7 | Butylone | CCC(NC)C(=O)C1=CC=C2OCOC2=C1 |
80 | 2-二甲氨基-1-[3,4-(亚甲二氧基)苯基]-1-丙酮 | 1-(3,4-Methylenedioxyphenyl)-2-dimethylaminopropan-1-one | 765231-58-1 | Dimethylone | CC(C(=O)C1=CC=C2OCOC2=C1)N(C)C |
81 | 乙卡西酮 | 1-Phenyl-2-ethylaminopropan-1-one | 18259-37-5 | Ethcathinone | CCNC(C)C(=O)C1=CC=CC=C1 |
82 | 3,4-亚甲二氧基乙卡西酮 | 1-(3,4-Methylenedioxyphenyl)-2-ethylaminopropan-1-one | 1112937-64-0 | Ethylone | CCNC(C)C(=O)C1=CC=C2OCOC2=C1 |
83 | 1-[3,4-(亚甲二氧基)苯基]-2-(N-吡咯烷基)-1-丁酮 | 1-(3,4-Methylenedioxyphenyl)-2-(1-pyrrolidinyl)butan-1-one | 784985-33-7 | MDPBP | CCC(C(=O)C1=CC=C2OCOC2=C1)N1CCCC1 |
84 | 1-[3,4-(亚甲二氧基)苯基]-2-(N-吡咯烷基)-1-丙酮 | 1-(3,4-Methylenedioxyphenyl)-2-(1-pyrrolidinyl)propan-1-one | 783241-66-7 | MDPPP | CCC(C(=O)C1=CC=C2OCOC2=C1)N1CCCC1 |
85 | 4-甲氧基甲卡西酮 | 1-(4-Methoxyphenyl)-2-methylaminopropan-1-one | 530-54-1 | Methedrone | CNC(C)C(=O)C1=CC=C(OC)C=C1 |
86 | 1-苯基-2-乙氨基-1-丁酮 | 1-Phenyl-2-ethylaminobutan-1-one | 1354631-28-9 | NEB | CCNC(CC)C(=O)C1=CC=CC=C1 |
87 | 1-苯基-2-甲氨基-1-戊酮 | 1-Phenyl-2-methylaminopentan-1-one | 879722-57-3 | Pentedrone | CCCC(NC)C(=O)C1=CC=CC=C1 |
88 | 1-苯基-2-(N-吡咯烷基)-1-丁酮 | 1-Phenyl-2-(1-pyrrolidinyl)butan-1-one | 13415-82-2 | α-PBP | CCC(C(=O)C1=CC=CC=C1)N1CCCC1 |
89 | 1-苯基-2-(N-吡咯烷基)-1-己酮 | 1-Phenyl-2-(1-pyrrolidinyl)hexan-1-one | 13415-86-6 | α-PHP | CCCCC(C(=O)C1=CC=CC=C1)N1CCCC1 |
90 | 1-苯基-2-(N-吡咯烷基)-1-庚酮 | 1-Phenyl-2-(1-pyrrolidinyl)heptan-1-one | 13415-83-3 | α-PHPP | CCCCCC(C(=O)C1=CC=CC=C1)N1CCCC1 |
91 | 1-苯基-2-(N-吡咯烷基)-1-戊酮 | 1-Phenyl-2-(1-pyrrolidinyl)pentan-1-one | 14530-33-7 | α-PVP | CCCC(C(=O)C1=CC=CC=C1)N1CCCC1 |
92 | 1-(2-噻吩基)-2-(N-吡咯烷基)-1-戊酮 | 1-(Thiophen-2-yl)-2-(1-pyrrolidinyl)pentan-1-one | 1400742-66-6 | α-PVT | CCCC(C(=O)C1=CC=CS1)N1CCCC1 |
93 | 2-(3-甲氧基苯基)-2-乙氨基环己酮 | 2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone | 1239943-76-0 | MXE | CCNC1(C2=CC=CC(OC)=C2)CCCCC1=O |
94 | 乙基去甲氯胺酮 | 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexanone | 1354634-10-8 | NENK | CCNC1(C2=C(Cl)C=CC=C2)CCCCC1=O |
95 | N,N-二烯丙基-5-甲氧基色胺 | 5-Methoxy-N,N-diallyltryptamine | 928822-98-4 | 5-MeO-DALT | C=CCN(CC=C)CCC1=CNC2=CC=C(OC)C=C12 |
96 | N,N-二异丙基-5-甲氧基色胺 | 5-Methoxy-N,N-diisopropyltryptamine | 4021-34-5 | 5-MeO-DiPT | COC1=CC=C2NC=C(CCN(C(C)C)C(C)C)C2=C1 |
97 | N,N-二甲基-5-甲氧基色胺 | 5-Methoxy-N,N-dimethyltryptamine | 1019-45-0 | 5-MeO-DMT | COC1=CC=C2NC=C(CCN(C)C)C2=C1 |
98 | N-甲基-N-异丙基-5-甲氧基色胺 | 5-Methoxy-N-isopropyl-N-methyltryptamine | 96096-55-8 | 5-MeO-MiPT | COC1=CC=C2NC=C(CCN(C)C(C)C)C2=C1 |
99 | α-甲基色胺 | alpha-Methyltryptamine | 299-26-3 | AMT | CC(N)CC1=CNC2=C1C=CC=C2 |
100 | 1,4-二苄基哌嗪 | 1,4-Dibenzylpiperazine | 1034-11-3 | DBZP | C1=CC=C(CN2CCN(CC3=CC=CC=C3)CC2)C=C1 |
101 | 1-(3-氯苯基)哌嗪 | 1-(3-Chlorophenyl)piperazine | 6640-24-0 | mCPP | ClC1=CC(N2CCNCC2)=CC=C1 |
102 | 1-(3-三氟甲基苯基)哌嗪 | 1-(3-Trifluoromethylphenyl)piperazine | 15532-75-9 | TFMPP | FC(F)(F)C1=CC=CC(N2CCNCC2)=C1 |
103 | 2-氨基茚满 | 2-Aminoindane | 2975-41-9 | 2-AI | NC1CC2=C(C=CC=C2)C1 |
104 | 5,6-亚甲二氧基-2-氨基茚满 | 5,6-Methylenedioxy-2-aminoindane | 132741-81-2 | MDAI | NC1CC2=C(C=C3OCOC3=C2)C1 |
105 | 2-二苯甲基哌啶 | 2-Diphenylmethylpiperidine | 519-74-4 | 2-DPMP | C1=CC=C(C(C2=CC=CC=C2)C2CCCCN2)C=C1 |
106 | 3,4-二氯哌甲酯 | Methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate | 1400742-68-8 | 3,4-CTMP | COC(=O)C(C1=CC=C(Cl)C(Cl)=C1)C1CCCCN1 |
107 | 乙酰芬太尼 | N-(1-Phenethylpiperidin-4-yl)-N-phenylacetamide | 3258-84-2 | Acetylfentanyl | CC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
108 | 3,4-二氯-N-[(1-二甲氨基环己基)甲基]苯甲酰胺 | 3,4-Dichloro-N-((1-(dimethylamino)cyclohexyl)methyl)benzamide | 55154-30-8 | AH-7921 | CN(C)C1(CNC(=O)C2=CC=C(Cl)C(Cl)=C2)CCCCC1 |
109 | 丁酰芬太尼 | N-(1-Phenethylpiperidin-4-yl)-N-phenylbutyramide | 1169-70-6 | Butyrylfentanyl | CCCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
110 | 哌乙酯 | Ethyl 2-phenyl-2-(piperidin-2-yl)acetate | 57413-43-1 | Ethylphenidate | CCOC(=O)C(C1=CC=CC=C1)C1CCCCN1 |
111 | 1-[1-(2-甲氧基苯基)-2-苯基乙基]哌啶 | 1-(1-(2-Methoxyphenyl)-2-phenylethyl)piperidine | 127529-46-8 | Methoxphenidine | COC1=C(C(CC2=CC=CC=C2)N2CCCCC2)C=CC=C1 |
112 | 芬纳西泮 | 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 51753-57-2 | Phenazepam | O=C1CN=C(C2=C(Cl)C=CC=C2)C2=CC(Br)=CC=C2N1 |
113 | β-羟基硫代芬太尼 | N-(1-(2-Hydroxy-2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropanamide | 1474-34-6 | β-Hydroxythiofentanyl | CCC(=O)N(C1=CC=CC=C1)C1CCN(CC(O)C2=CC=CS2)CC1 |
114 | 4-氟丁酰芬太尼 | N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide | 244195-31-1 | 4-Fluorobutyrfentanyl | CCCC(=O)N(C1=CC=C(F)C=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
115 | 异丁酰芬太尼 | N-(1-Phenethylpiperidin-4-yl)-N-phenylisobutyramide | 119618-70-1 | Isobutyrfentanyl | CC(C)C(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
116 | 奥芬太尼 | N-(2-Fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide | 101343-69-5 | Ocfentanyl | COCC(=O)N(C1=C(F)C=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
117 | 丙烯酰芬太尼 | N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide | 82003-75-6 | Acrylfentanyl | C=CC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
118 | 卡芬太尼 | Methyl4-(N-phenylpropionamido)-1-phenethylpiperidine-4-carboxylate | 59708-52-0 | CarfentanylCarfentanil | CCC(=O)N(C1=CC=CC=C1)C1(C(=O)OC)CCN(CCC2=CC=CC=C2)CC1 |
119 | 呋喃芬太尼 | N-(1-Phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide | 101345-66-8 | Furanylfentanyl | O=C(C1=CC=CO1)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
120 | 戊酰芬太尼 | N-(1-Phenethylpiperidin-4-yl)-N-phenylpentanamide | 122882-90-0 | Valerylfentanyl | CCCCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
121 | N-甲基-N-(2-二甲氨基环己基)-3,4-二氯苯甲酰胺 | 3,4-Dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide | 121348-98-9 | U-47700 | CN(C)C1CCCCC1N(C)C(=O)C1=CC=C(Cl)C(Cl)=C1 |
122 | 1-环己基-4-(1,2-二苯基乙基)哌嗪 | 1-Cyclohexyl-4-(1,2-diphenylenthyl)piperazine | 52694-55-0 | MT-45 | C1=CC=C(CC(C2=CC=CC=C2)N2CCN(C3CCCCC3)CC2)C=C1 |
123 | 4-甲氧基甲基苯丙胺 | N-Methyl--1-(4-methoxyphenyl)propan-2-amine | 22331-70-0 | PMMA | CNC(C)CC1=CC=C(OC)C=C1 |
124 | 2-氨基-4-甲基-5-(4-甲基苯基)-4,5-二氢恶唑 | 4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine | 1445569-01-6 | 4,4'DMAR | CC1=CC=C(C2OC(N)=NC2C)C=C1 |
125 | 4-氯乙卡西酮 | 1-(4-Chlorophenyl)-2-(ethylamino)propan-1-one | 14919-85-8 | 4-CEC | CCNC(C)C(=O)C1=CC=C(Cl)C=C1 |
126 | 1-[3,4-(亚甲二氧基)苯基]-2-乙氨基-1-戊酮 | 1-(3,4-Methylenedioxyphenyl)-2-(ethylamino)pentan-1-one | 727641-67-0 | N-Ethylpentylone | CCCC(NCC)C(=O)C1=CC=C2OCOC2=C1 |
127 | 1-(4-氯苯基)-2-(N-吡咯烷基)-1-戊酮 | 1-(4-Chlorophenyl)-2-(1-pyrrolidinyl)pentan-1-one | 5881-77-6 | 4-Cl-α-PVP | CCCC(C(=O)C1=CC=C(Cl)C=C1)N1CCCC1 |
128 | 1-[3,4-(亚甲二氧基)苯基]-2-二甲氨基-1-丁酮 | 1-(3,4-Methylenedioxyphenyl)-2-(dimethylamino)butan-1-one | 802286-83-5 | Dibutylone | CCC(C(=O)C1=CC=C2OCOC2=C1)N(C)C |
129 | 1-[3,4-(亚甲二氧基)苯基]-2-甲氨基-1-戊酮 | 1-(3,4-Methylenedioxyphenyl)-2-(methylamino)pentan-1-one | 698963-77-8 | Pentylone | CCCC(NC)C(=O)C1=CC=C2OCOC2=C1 |
130 | 1-苯基-2-乙氨基-1-己酮 | 1-Phenyl-2-(ethylamino)hexan-1-one | 802857-66-5 | N-Ethylhexedrone | CCCCC(NCC)C(=O)C1=CC=CC=C1 |
131 | 1-(4-甲基苯基)-2-(N-吡咯烷基)-1-己酮 | 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)hexan-1-one | 34138-58-4 | 4-MPHP | CCCCC(C(=O)C1=CC=C(C)C=C1)N1CCCC1 |
132 | 1-(4-氯苯基)-2-(N-吡咯烷基)-1-丙酮 | 1-(4-Chlorophenyl)-2-(1-pyrrolidinyl)propan-1-one | 28117-79-5 | 4-Cl-α-PPP | CC(C(=O)C1=CC=C(Cl)C=C1)N1CCCC1 |
133 | 1-[2-(5,6,7,8-四氢萘基)]-2-(N-吡咯烷基)-1-戊酮 | 1-(5,6,7,8-Tetrahydronaphthalen-2-yl)-2-(1-pyrrolidinyl)pentan-1-one | 2304915-07-7 | β-TH-Naphyrone | CCCC(C(=O)C1=CC2=C(C=C1)CCCC2)N1CCCC1 |
134 | 1-(4-氟苯基)-2-(N-吡咯烷基)-1-己酮 | 1-(4-Fluorophenyl)-2-(1-pyrrolidinyl)hexan-1-one | 2230706-09-7 | 4-F-α-PHP | CCCCC(C(=O)C1=CC=C(F)C=C1)N1CCCC1 |
135 | 4-乙基甲卡西酮 | 1-(4-Ethylphenyl)-2-(methylamino)propan-1-one | 1225622-14-9 | 4-EMC | CCC1=CC=C(C(=O)C(C)NC)C=C1 |
136 | 1-(4-甲基苯基)-2-乙氨基-1-戊酮 | 1-(4-Methylphenyl)-2-(ethylamino)pentan-1-one | 746540-82-9 | 4-MEAPP | CCCC(NCC)C(=O)C1=CC=C(C)C=C1 |
137 | 1-(4-甲基苯基)-2-甲氨基-3-甲氧基-1-丙酮 | 1-(4-Methylphenyl)-2-(methylamino)-3-methoxypropan-1-one | 2166915-02-0 | Mexedrone | CNC(COC)C(=O)C1=CC=C(C)C=C1 |
138 | 1-[3,4-(亚甲二氧基)苯基]-2-(N-吡咯烷基)-1-己酮 | 1-(3,4-Methylenedioxyphenyl)-2-(1-pyrrolidinyl)hexan-1-one | 776994-64-0 | MDPHP | CCCCC(C(=O)C1=CC=C2OCOC2=C1)N1CCCC1 |
139 | 1-(4-甲基苯基)-2-甲氨基-1-戊酮 | 1-(4-Methylphenyl)-2-(methylamino)pentan-1-one | 1373918-61-6 | 4-MPD | CCCC(NC)C(=O)C1=CC=C(C)C=C1 |
140 | 1-(4-甲基苯基)-2-二甲氨基-1-丙酮 | 1-(4-Methylphenyl)-2-(dimethylamino)propan-1-one | 1157738-08-3 | 4-MDMC | CC1=CC=C(C(=O)C(C)N(C)C)C=C1 |
141 | 3,4-亚甲二氧基丙卡西酮 | 1-(3,4-Methylenedioxyphenyl)-2-(propylamino)propan-1-one | 201474-93-3 | Propylone | CCCNC(C)C(=O)C1=CC=C2OCOC2=C1 |
142 | 1-(4-氯苯基)-2-乙氨基-1-戊酮 | 1-(4-Chlorophenyl)-2-(ethylamino)pentan-1-one | 暂无 | 4-Cl-EAPP | CCCC(NCC)C(=O)C1=CC=C(Cl)C=C1 |
143 | 1-苯基-2-(N-吡咯烷基)-1-丙酮 | 1-Phenyl-2-(1-pyrrolidinyl)propan-1-one | 19134-50-0 | α-PPP | CC(C(=O)C1=CC=CC=C1)N1CCCC1 |
144 | 1-(4-氯苯基)-2-甲氨基-1-戊酮 | 1-(4-Chlorophenyl)-2-(methylamino)pentan-1-one | 2167949-43-9 | 4-Cl-Pentedrone | CCCC(NC)C(=O)C1=CC=C(Cl)C=C1 |
145 | 3-甲基-2-[1-(4-氟苄基)吲唑-3-甲酰胺基]丁酸甲酯 | N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | 1715016-76-4 | AMB-FUBINACA | COC(=O)C(NC(=O)C1=NN(CC2=CC=C(F)C=C2)C2=C1C=CC=C2)C(C)C |
146 | 1-(4-氟苄基)-N-(1-金刚烷基)吲唑-3-甲酰胺 | N-(1-Adamantyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | 2180933-90-6 | FUB-APINACA | O=C(NC12CC3CC(CC(C3)C1)C2)C1=NN(CC2=CC=C(F)C=C2)C2=C1C=CC=C2 |
147 | N-(1-氨甲酰基-2,2-二甲基丙基)-1-(环己基甲基)吲唑-3-甲酰胺 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | 1863065-92-2 | ADB-CHMINACA | CC(C)(C)C(NC(=O)C1=NN(CC2CCCCC2)C2=C1C=CC=C2)C(N)=O |
148 | N-(1-氨甲酰基-2,2-二甲基丙基)-1-(4-氟苄基)吲唑-3-甲酰胺 | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | 1445583-51-6 | ADB-FUBINACA | CC(C)(C)C(NC(=O)C1=NN(CC2=CC=C(F)C=C2)C2=C1C=CC=C2)C(N)=O |
149 | 3,3-二甲基-2-[1-(5-氟戊基)吲唑-3-甲酰氨基]丁酸甲酯 | N-(1-Methoxy-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | 1715016-75-3 | 5F-ADB | COC(=O)C(NC(=O)C1=NN(CCCCCF)C2=C1C=CC=C2)C(C)(C)C |
150 | 3-甲基-2-[1-(环己基甲基)吲哚-3-甲酰氨基]丁酸甲酯 | N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indole-3-carboxamide | 1971007-94-9 | AMB-CHMICA | COC(=O)[C@@H](NC(=O)C1=CN(CC2CCCCC2)C2=C1C=CC=C2)C(C)C |
151 | 1-(5-氟戊基)-2-(1-萘甲酰基)苯并咪唑 | (1-(5-Fluoropentyl)-1H-benzimidazol-2-yl)(naphthalen-1-yl)methanone | 1984789-90-3 | BIM-2201 | O=C(C1=CC=CC2=C1C=CC=C2)C1=NC2=C(C=CC=C2)N1CCCCCF |
152 | 1-(5-氟戊基)吲哚-3-甲酸-1-萘酯 | Naphthalen-1-yl-1-(5-fluoropentyl)-1H-indole-3-carboxylate | 2042201-16-9 | NM-2201 | O=C(OC1=CC=CC2=C1C=CC=C2)C1=CN(CCCCCF)C2=C1C=CC=C2 |
153 | 2-苯基-2-甲氨基环己酮 | 2-Phenyl-2-(methylamino)cyclohexanone | 7063-30-1 | DCK | CNC1(C2=CC=CC=C2)CCCCC1=O |
154 | 3-甲基-5-[2-(8-甲基-3-苯基-8-氮杂环[3,2,1]辛烷基)]-1,2,4-噁二唑 | 8-Methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)-3-phenyl-8-aza-bicyclo[3.2.1]octane | 146659-37-2 | RTI-126 | CC1=NOC([C@H]2C(C3=CC=CC=C3)CC34[C@H](CC[C@H]23)N4C)=N1 |
155 | 4-氟异丁酰芬太尼 | N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide | 244195-32-2 | 4-FIBF | CC(C)C(=O)N(C1=CC=C(F)C=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
156 | 四氢呋喃芬太尼 | N-Phenyl-N-(1-phenethylpiperidin-4-yl)tetrahydrofuran-2-carboxamide | 2142571-01-3 | THF-F | O=C(C1CCCO1)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
157 | 氟胺酮 | 2-(2-Fluorophenyl)-2-(methylamino)cyclohexan-1-one | 111982-50-4 | 2-FDCKFluoroketamine | CNC1(C2=C(F)C=CC=C2)CCCCC1=O |
158 | (6aR,10aR)-3-(1,1-二甲基庚基)-6a,7,10,10a-四氢-1-羟基-6,6-二甲基-6H-二苯并[b,d]吡喃-9-甲醇 | (6aR,10aR)-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzob,dpyran-9-methanol | 112830-95-2 | HU-210 | CCCCCCC(C)(C)C1=CC2=C(C(O)=C1)[C@@H]1CC(CO)=CC[C@H]1C(C)(C)O2 |
159 | 1-[3,4-(亚甲二氧基)苯基]-2-丁氨基-1-戊酮 | 1-(3,4-Methylenedioxypheny1)-2-(butylamino)pentan-1-one | 688727-54-0 | N-Butylpentylone | CCCCNC(CCC)C(=O)C1=CC=C2OCOC2=C1 |
160 | 1-[3,4-(亚甲二氧基)苯基]-2-苄氨基-1-丙酮 | 1-(3,4-Methylenedioxyphenyl)-2-(benzylamino)propan-1-one | 1387636-19-2 | BMDP | CC(NCC1=CC=CC=C1)C(=O)C1=CC=C2OCOC2=C1 |
161 | 1-[3,4-(亚甲二氧基)苯基]-2-乙氮基-1-丁酮 | 1-(3,4-Methylenedioxypheny1)-2-(ethylamino)butan-1-one | 802855-66-9 | Eutylone | CCNC(CC)C(=O)C1=CC=C2OCOC2=C1 |
162 | 2-乙氨基-1-苯基-1-庚酮 | 2-(Ethylamino)-1-phenylheptan-1-one | 2514784-72-4 | N-Ethylheptedrone | CCCCCC(NCC)C(=O)C1=CC=CC=C1 |
163 | 1-(4-氯苯基)-2-二甲氨基-1-丙酮 | 1-(4-Chlorophenyl)-2-(dimethylamino)propan-1-one | 1157667-29-2 | 4-CDMC | CC(C(=O)C1=CC=C(Cl)C=C1)N(C)C |
164 | 2-丁氨基-1-苯基-1-己酮 | 2-(Butylamino)-1-phenylhexan-1-one | 802576-87-0 | N-Butylhexedrone | CCCCNC(CCCC)C(=O)C1=CC=CC=C1 |
165 | 1-[1-(3-甲氧基苯基)环己基]哌啶 | 1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine | 72242-03-6 | 3-MeO-PCP | COC1=CC(C2(N3CCCCC3)CCCCC2)=CC=C1 |
166 | a-甲基-5-甲氧基色胺 | 1-(5-Methoxy-1H-indol-3-yl)propan-2-amine | 1137-04-8 | 5-MeO-AMT | COC1=CC=C2NC=C(CC(C)N)C2=C1 |
167 | 科纳唑仑 | 6-(2-Chlorophenyl)-1-methy1-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | 33887-02-4 | Clonazolam | CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C3=CC([N+](=O)[O-])=CC=C3N12 |
168 | 二氯西泮 | 7-Chloro-5-(2-chlorophenyl)-1-methy1-1,3dihydro-2H-benzo[e][1,4]diazepin-2-one | 2894-68-0 | Didazepam | CN1C(=O)CN=C(C2=C(Cl)C=CC=C2)C2=CC(Cl)=CC=C21 |
169 | 氟阿普唑仑 | 8-Chloro-6-(2-fluorophenyl)-1-methy1-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | 28910-91-0 | Flualprazolam | CC1=NN=C2CN=C(C3=C(F)C=CC=C3)C3=CC(Cl)=CC=C3N12 |
170 | 异丙托尼秦 | N,N-Diethy1-2-(2-(4-isopropoxybenzy1)-5-nitro-1H-benzo[d]imidazo1-1-yl)ethan-1-amine | 14188-81-9 | Isotonitazene | CCN(CC)CCN1C(CC2=CC=C(OC(C)C)C=C2)=NC2=CC([N+](=O)[O-])=CC=C21 |
171 | 氟溴唑仑 | 8-Bromo-6-(2-fluorophenyl)-1-methy1-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | 612526-40-6 | Flubromazolam | CC1=NN=C2CN=C(C3=C(F)C=CC=C3)C3=CC(Br)=CC=C3N12 |
172 | 1-(1,2-二苯基乙基)哌啶 | 1-(1,2-Diphenylethyl)piperidine | 36794-52-2 | Diphenidine | C1=CC=C(CC(C2=CC=CC=C2)N2CCCCC2)C=C1 |
173 | 2-(3-氟苯基)-3-甲基吗啉 | 2-(3-Fhuorophenyl)-3-methylmorpholine | 1350768-28-3 | 3-EPM3-Fluorophenmetrazine | CC1NCCOC1C1=CC=CC(F)=C1 |
174 | 溴啡 | 1-(1-(1-(4-Bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one | 2244737-98-0 | Brorphine | CC(C1=CC=C(Br)C=C1)N1CCC(N2C(=O)NC3=C2C=CC=C3)CC1 |
175 | 美托尼秦 | N,N-Diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine | 14680-51-4 | Metonitazene | CCN(CC)CCN1C(CC2=CC=C(OC)C=C2)=NC2=CC([N+](=O)[O-])=CC=C21 |
176 | 2-甲基布桂嗪 | 1-(4-Cinnamyl-2-methylpiperazin-1-yl)butan-1-one | 98608-61-8 | 2-Methyl-AP-237 | CCCC(=O)N1CCN(C/C=C/C2=CC=CC=C2)CC1C |
177 | 去硝基依托尼秦 | 2-(2-(4-Ethoxybenzyl)-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine | 14030-76-3 | Etazene | CCOC1=CC=C(CC2=NC3=C(C=CC=C3)N2CCN(CC)CC)C=C1 |
178 | 丙托尼秦 | N,N-Diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzo[d]imidazol-1-yl)ethan-1-amine | 95958-84-2 | Protonitazene | CCCOC1=CC=C(CC2=NC3=CC([N+](=O)[O-])=CC=C3N2CCN(CC)CC)C=C1 |
179 | 依托吡尼秦 | 2-(4-Ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzo[d]imidazole | 2785346-75-8 | Etonitazepyne | CCOC1=CC=C(CC2=NC3=CC([N+](=O)[O-])=CC=C3N2CCN2CCCC2)C=C1 |
180 | 丁托尼秦 | 2-(2-(4-Butoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine | 95810-54-1 | Butonitazene | CCCCOC1=CC=C(CC2=NC3=CC([N+](=O)[O-])=CC=C3N2CCN(CC)CC)C=C1 |
181 | 丙托吡尼秦 | 5-Nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzo[d]imidazole | 暂无 | Protonitazepyne | CCCOC1=CC=C(CC2=NC3=CC([N+](=O)[O-])=CC=C3N2CCN2CCCC2)C=C1 |
182 | N-去乙基异丙托尼秦 | N-Ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine | 2732926-24-6 | N-DesethylIsotonitazene | CCNCCN1C(CC2=CC=C(OC(C)C)C=C2)=NC2=CC([N+](=O)[O-])=CC=C21 |
183 | N-去乙基依托尼秦 | 2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N-ethylethan-1-amine | 2732926-26-8 | N-DesethylEtonitazene | CCNCCN1C(CC2=CC=C(OCC)C=C2)=NC2C=C([N+](=O)[O-])C=CC21 |
184 | 亚乙氧尼秦 | 2-(2-((2,3-Dihydrobenzofuran-5-yl)methyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine | 暂无 | Ethyleneoxynitazene | CCN(CC)CCN1C(CC2=CC=C3OCCC3=C2)=NC2=CC([N+](=O)[O-])=CC=C21 |
185 | 1-(苯并呋喃-6-基)-2-丙胺 | 1-(Benzofuran-6-yl)propan-2-amine | 286834-85-3 | 6-APB | CC(N)CC1=CC=C2C=COC2=C1 |
186 | 1-(苯并呋喃-5-基)-2-丙胺 | 1-(Benzofuran-5-yl)propan-2-amine | 286834-81-9 | 5-APB | CC(N)CC1=CC=C2OC=CC2=C1 |
187 | 甲基烯丙基麦司卡林 | 2-(3,5-Dimethoxy-4-((2-methylallyl)oxy)phenyl)ethan-1-amine | 207740-41-8 | Methallylescaline | C=C(C)COC1=C(OC)C=C(CCN)C=C1OC |
188 | 乙基麦司卡林 | 2-(4-Ethoxy-3,5-dimethoxyphenyl)ethan-1-amine | 39201-82-6 | Escaline | CCOC1=C(OC)C=C(CCN)C=C1OC |
189 | 丙基麦司卡林 | 2-(3,5-Dimethoxy-4-propoxyphenyl)ethan-1-amine | 39201-78-0 | Proscaline | CCCOC1=C(OC)C=C(CCN)C=C1OC |
190 | 2-氟乙基苯丙胺 | N-Ethyl-1-(2-fluorophenyl)propan-2-amine | 3823-29-8 | 2-FEA | CCNC(C)CC1=C(F)C=CC=C1 |
191 | 3-氟乙基苯丙胺 | N-Ethyl-1-(3-fluorophenyl)propan-2-amine | 725676-94-8 | 3-FEA | CCNC(C)CC1=CC=CC(F)=C1 |
192 | 4-氟乙基苯丙胺 | N-Ethyl-1-(4-fluorophenyl)propan-2-amine | 3823-30-1 | 4-FEA | CCNC(C)CC1=CC=C(F)C=C1 |
193 | 1-[1-(4-甲氧基苯基)环己基]哌啶 | 1-(1-(4-Methoxyphenyl)cyclohexyl)piperidine | 2201-35-6 | 4-MeO-PCP | COC1=CC=C(C2(N3CCCCC3)CCCCC2)C=C1 |
194 | 2-乙氨基-2-苯基环己酮 | 2-(Ethylamino)-2-phenylcyclohexan-1-one | 6740-82-5 | 2-oxo-PCE | CCNC1(C2=CC=CC=C2)CCCCC1=O |
195 | 3-[1-(哌啶-1-基)环己基]苯酚 | 3-(1-(Piperidin-1-yl)cyclohexyl)phenol | 79787-43-2 | 3-HO-PCP | OC1=CC(C2(N3CCCCC3)CCCCC2)=CC=C1 |
196 | 溴胺酮 | 2-(2-Bromophenyl)-2-(methylamino)cyclohexan-1-one | 120807-70-7 | 2-BDCK | CNC1(C2=C(Br)C=CC=C2)CCCCC1=O |
197 | 2-乙氨基-2-(2-氟苯基)环己酮 | 2-(Ethylamino)-2-(2-fluorophenyl)cyclohexan-1-one | 2850352-64-4 | 2-FXE | CCNC1(C2=C(F)C=CC=C2)CCCCC1=O |
198 | 甲基胺酮 | 2-(Methylamino)-2-(2-methylphenyl)cyclohexan-1-one | 7063-37-8 | 2-MDCK | CNC1(C2=C(C)C=CC=C2)CCCCC1=O |
199 | 2-乙氨基-2-(3-甲基苯基)环己酮 | 2-(Ethylamino)-2-(3-methylphenyl)cyclohexan-1-one | 2666932-45-0 | DMXE | CCNC1(C2=CC(C)=CC=C2)CCCCC1=O |
200 | 1-(4-氟-3-甲基苯基)-2-(吡咯烷-1-基)-1-戊酮 | 1-(4-Fluoro-3-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one | 暂无 | 4-F-3-MPVP | CCCC(C(=O)C1=CC=C(F)C(C)=C1)N1CCCC1 |
201 | 1-[3,4-(亚甲二氧基)苯基]-2-二甲氨基-1-戊酮 | 1-(3,4-Methylenedioxyphenyl)-2-(dimethylamino)pentan-1-one | 803614-36-0 | Dipentylone | CCCC(C(=O)C1=CC=C2OCOC2=C1)N(C)C |
202 | 1-[3,4-(亚甲二氧基)苯基]-2-环己基氨基-1-丙酮 | 1-(3,4-Methylenedioxyphenyl)-2-(cyclohexylamino)propan-1-one | 2972185-69-4 | N-Cyclohexylmethylone | CC(NC1CCCCC1)C(=O)C1=CC=C2OCOC2=C1 |
203 | 1-[3,4-(亚甲二氧基)苯基]-2-丁氨基-1-丁酮 | 1-(3,4-Methylenedioxyphenyl)-2-(butylamino)butan-1-one | 暂无 | N-Butylbutylone | CCCCNC(CC)C(=O)C1=CC=C2OCOC2=C1 |
204 | 1-[3,4-(亚甲二氧基)苯基]-2-丙氨基-1-丁酮 | 1-(3,4-Methylenedioxyphenyl)-2-(propylamino)butan-1-one | 802286-81-3 | N-Propylbutylone | CCCNC(CC)C(=O)C1=CC=C2OCOC2=C1 |
205 | 4-甲基-1-苯基-2-(吡咯烷-1-基)-1-戊酮 | 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one | 2181620-71-1 | α-PiHP | CC(C)CC(C(=O)C1=CC=CC=C1)N1CCCC1 |
206 | 2-(仲丁基氨基)-1-苯基-1-戊酮 | 2-(sec-Butylamino)-1-phenylpentan-1-one | 18296-64-5 | N-sec-Butylpentedrone | CCCC(NC(C)CC)C(=O)C1=CC=CC=C1 |
207 | 环丙甲酰麦角酰二乙胺 | (6aR,9R)-4-(Cyclopropanecarbonyl)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide | 2767597-50-0 | 1cP-LSD | CCN(CC)C(=O)[C@@H]1C=C2C3=CC=CC4=C3C(=CN4C(=O)C3CC3)C[C@H]2N(C)C1 |
208 | 戊酰麦角酰二乙胺 | (6aR,9R)-N,N-Diethyl-7-methyl-4-pentanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide | 3028950-70-8 | 1V-LSD | CCCCC(=O)N1C=C2C[C@@H]3C(=C[C@@H](C(=O)N(CC)CC)CN3C)C3=CC=CC1=C23 |
209 | 丙酰麦角酰二乙胺 | (6aR,9R)-N,N-Diethyl-7-methyl-4-propionyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide | 2349358-81-0 | 1P-LSD | CCC(=O)N1C=C2C[C@@H]3C(=C[C@@H](C(=O)N(CC)CC)CN3C)C3=CC=CC1=C23 |
210 | N-甲基-N-异丙基-4-羟基色胺 | 3-(2-(Isopropyl(methyl)amino)ethyl)-1H-indol-4-ol | 77872-43-6 | 4-HO-MiPT | CC(C)N(C)CCC1=CNC2=CC=CC(O)=C12 |
211 | N,N-二甲基-4-乙酰氧基色胺 | 3-(2-(Dimethylamino)ethyl)-1H-indol-4-yl acetate | 92292-84-7 | 4-AcO-DMT | CC(=O)OC1=C2C(CCN(C)C)=CNC2=CC=C1 |
212 | 波玛唑仑 | 8-Bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | 71368-80-4 | Bromazolam | CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Br)=CC=C3N12 |
213 | 氟溴西泮 | 7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one | 2647-50-9 | Flubromazepam | O=C1CN=C(C2=C(F)C=CC=C2)C2=CC(Br)=CC=C2N1 |
214 | 卡痛 | Mitragyna speciosa | 无 | Kratom | |
215 | 帽柱木碱 | (E)-Methyl 2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate | 4098-40-2 | Mitragynine | CC[C@@H]1CN2CCC3=C(NC4=CC=CC(OC)=C34)[C@@H]2C[C@@H]1/C(=C\OC)C(=O)OC |
216 | 7-羟基帽柱木碱 | (E)-Methyl 2-((2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate | 174418-82-7 | 7-HydroxyMitragynine | CC[C@@H]1CN2CC[C@@]3(O)C(=NC4=CC=CC(OC)=C43)[C@H]2C[C@@H]1/C(=C\OC)C(=O)OC |
217 | 美托咪酯 | Methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate | 5377-20-8 | Metomidate | COC(=O)C1=CN=CN1C(C)C1=CC=CC=C1 |
218 | 异丙帕酯 | Isopropyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate | 792842-51-4 | Isopropoxate | CC(C)OC(=O)C1=CN=CN1C(C)C1=CC=CC=C1 |
219 | 丙帕酯 | Propyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate | 7036-58-0 | Propoxate | CCCOC(=O)C1=CN=CN1C(C)C1=CC=CC=C1 |
220 | 三氟乙咪酯 | 2,2,2-trifluoroethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate | 2169968-54-9 | TF-Etomidate | C[C@H](C1=CC=CC=C1)N1C=NC=C1C(=O)OCC(F)(F)F |
221 | 丁托咪酯 | butyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate | 112367-53-0 | Butomidate | CCCCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 |
222 | 仲丁咪酯 | butan-2-yl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate | 暂无 | sec-Butomidate | CCC(C)OC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 |
223 | 异丁咪酯 | 2-methylpropyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate | 暂无 | Isobutomidate | CC(C)COC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 |
224 | 4-氟依托咪酯 | ethyl 3-[1-(4-fluorophenyl)ethyl]imidazole-4-carboxylate | 84962-75-4 | 4F-Etomidate | CCOC(=O)C1=CN=CN1C(C)C1=CC=C(F)C=C1 |
225 | 甲氧羰基环丙咪酯 | (1-methoxycarbonylcyclopropyl)3-[(1R)-1-phenylethyl]imidazole-4-carboxylate | 1446482-29-6 |
ABP-700 | COC(=O)C1(OC(=O)C2=CN=CN2[C@H](C)C2=CC=CC=C2)CC1 |
226 | 2,6-二氯-3-氟依托咪酯 | Ethyl-1-(1-(2,6-dichloro-3-fluorophenyl)ethyl)-1H-imidazole-5-carboxylate | 暂无 | 2,6-diCl-3F-Etomidate | CCOC(=O)C1=CN=CN1[C@H](C)C1=C(Cl)C=CC(F)=C1Cl |
227 | 1-[3,4-(亚甲二氧基)苯基]-2-异丙氨基-1-丁酮 | 1-(1,3-benzodioxol-5-yl)-2-(propan-2-ylamino)butan-1-one | 801171-25-5 | N-Isopropylbutylone | CCC(NC(C)C)C(=O)C1=CC=C2OCOC2=C1 |
228 | 噻吩丙胺 | 1-thiophen-2-ylpropan-2-amine | 30433-93-3 | Thienoamphetamine | CC(N)CC1=CC=CS1 |
229 | 1-[1-(3-甲氧基苯基)环己基]吡咯烷 | 1-[1-(3-methoxyphenyl)cyclohexyl]pyrrolidine | 1364933-79-8 | 3-MeO-PCPy | COC1=CC=CC(C2(N3CCCC3)CCCCC2)=C1 |
230 | 2-苯基-2-丙氨基环己酮 | 2-phenyl-2-(propylamino)cyclohexan-1-one | 7015-53-4 | 2-oxo-PCPr | CCCNC1(C2=CC=CC=C2)CCCCC1=O |
231 | 六氢大麻酚 | 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | 6692-85-9 | hexahydrocannabinol(HHC) | CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)CC21 |
232 | 氨奈普汀 | Amineptine | 57574-09-1 | O=C(O)CCCCCCNC1C2=C(C=CC=C2)CCC2=C1C=CC=C2 |
|
233 | 1-(4-溴-2,5-二甲氧基苯基)-2-丙胺 | 1-(4-Bromo-2,5-dimethoxyphenyl)propan-2-amine | 64638-07-9 | DOB | COC1=CC(CC(C)N)=C(OC)C=C1Br |
234 | 2,5-二甲氧基-4-溴苯乙胺 | 4-Bromo-2,5-dimethoxyphenethylamine | 66142-81-2 | 2-CB | COC1=CC(CCN)=C(OC)C=C1Br |
235 | 1-丁基-3-(1-萘甲酰基)吲哚 | (1-Butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 208987-48-8 | JWH-073 | CCCCN1C=C(C(=O)C2=C3C=CC=CC3=CC=C2)C2=C1C=CC=C2 |
236 | 恰特草 | Catha edulis Forssk | Khat | ||
237 | 卡西酮 | Cathinone | 5265-18-9 | CC(C(=O)C1=CC=CC=C1)N |
|
238 | 二乙基色胺 | 3-[2-(Diethylamino)ethyl]indole | 7558-72-7 | DET | CCN(CC)CCC1=CNC2=C1C=CC=C2 |
239 | 1-(2,5-二甲氧基-4-甲基苯基)-2-丙胺 | 1-(2,5-Dimethoxy-4-methylphenyl)propan-2-amine | 15588-95-1 | DOM | COC1=C(C)C=C(OC)C(CC(C)N)=C1 |
240 | 二甲氧基苯丙胺 | 1-(2,5-Dimethoxyphenyl)propan-2-amine | 2801-68-5 | DMA | COC1=CC=C(OC)C(CC(C)N)=C1 |
241 | 2,5-二甲氧基-4-碘苯乙胺 | 2,5-Dimethoxy-4-iodophenethylamine | 69587-11-7 | 2C-I | COC1=CC(CCN)=C(OC)C=C1I |
242 | 2,5-二甲氧基苯乙胺 | 2,5-Dimethoxyphenethylamine | 3600-86-0 | 2C-H | COC1=CC=C(OC)C(CCN)=C1 |
243 | 二甲基苯丙胺 | N,N-Dimethyl-1-phenylpropan-2-amine | 4075-96-1 | Dimethylamphetamine | CC(CC1=CC=CC=C1)N(C)C |
244 | 二甲基色胺 | N,N-Dimethyltryptamine | 61-50-7 | DMT | CN(C)CCC1=CNC2=C1C=CC=C2 |
245 | 6,6,9-三甲基-3-(3-甲基辛-2-基)-7,8,9,10-四氢-6H-苯并[c]色烯-1-醇 | 6,6,9-Trimethyl-3-(3-methyloctan-2-yl)-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | 32904-22-6 | DMHP | CCCCCC(C)C(C)C1=CC2=C(C3=C(CCC(C)C3)C(C)(C)O2)C(O)=C1 |
246 | Δ9-四氢大麻酚 | 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol | 1972-08-3 | Dronabinol Δ9-THC |
CCCCCC1=CC2=C(C(O)=C1)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2 |
247 | 依他喹酮 | 3-(2-Ethylphenyl)-2-methylquinazolin-4(3H)-one | 7432-25-9 | Etaqualone | CCC1=C(N2C(C)=NC3=C(C=CC=C3)C2=O)C=CC=C1 |
248 | 1-(4-乙基-2,5-二甲氧基苯基)-2-丙胺 | 1-(4-Ethyl-2,5-dimethoxyphenyl)propan-2-amine | 22004-32-6 | DOET | CCC1=CC(=C(C=C1OC)CC(C)N)OC |
249 | 乙环利定 | N-Ethyl-1-phenylcyclohexanamine | 2201-15-2 | Eticyclidine PCE |
CCNC1(C2=CC=CC=C2)CCCCC1 |
250 | 乙色胺 | alpha-Ethyltryptamine | 2235-90-7 | Etryptamine | CCC(N)CC1=CNC2=C1C=CC=C2 |
251 | 芬乙茶碱 | 1,3-Dimethyl-7-(2-((1-phenylpropan-2-yl)amino)ethyl)-1H-purine-2,6-dione | 3736-08-1 | Fenetylline | CC(CC1=CC=CC=C1)NCCN1C=NC2=C1C(=O)N(C)C(=O)N2C |
252 | 1-(5-氟戊基)-3-(2-碘苯甲酰基)吲哚 | (1-(5-Fluoropentyl)-1H-indol-3-yl)(2-iodophenyl)methanone | 335161-03-0 | AM-694 | O=C(C1=C(I)C=CC=C1)C1=CN(CCCCCF)C2=C1C=CC=C2 |
253 | 1-(5-氟戊基)-3-(1-萘甲酰基)吲哚 | (1-(5-Fluoropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 335161-24-5 | AM-2201 | O=C(C1=C2C=CC=CC2=CC=C1)C1=CN(CCCCCF)C2=C1C=CC=C2 |
254 | 左旋甲基苯丙胺 | (R)-N-Methyl-1-phenylpropan-2-amine | 33817-09-3 | Levomethamphetamine | CN[C@H](C)CC1=CC=CC=C1 |
255 | 麦角二乙胺 | (6aR,9R)-N,N-Diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide | 50-37-3 | Lysergide LSD |
CCN(CC)C(=O)[C@@H]1C=C2C3=CC=CC4=C3C(=CN4)C[C@H]2N(C)C1 |
256 | 甲氯喹酮 | 3-(2-Chlorophenyl)-2-methylquinazolin-4(3H)-one | 340-57-8 | Mecloqualone | CC1=NC2=C(C=CC=C2)C(=O)N1C1=C(Cl)C=CC=C1 |
257 | 麦司卡林 | 2-(3,4,5-Trimethoxyphenyl)ethanamine | 54-04-6 | Mescaline | COC1=C(OC)C(OC)=CC(CCN)=C1 |
258 | 右旋甲基苯丙胺 | (S)-N-Methyl-1-phenylpropan-2-amine | 537-46-2 | Dextromethamphetamine | CN[C@@H](C)CC1=CC=CC=C1 |
259 | 甲基苯丙胺 | N-Methyl-1-phenylpropan-2-amine | 7632-10-2 | Methamphetamine | CNC(C)CC1=CC=CC=C1 |
260 | 甲卡西酮 | 2-(Methylamino)-1-phenylpropan-1-one | 5650-44-2 | Methcathinone | CNC(C)C(=O)C1=CC=C(C)C=C1 |
261 | 5-甲氧基-3,4-亚甲二氧基苯丙胺 | 1-(5-Methoxy-3,4-methylenedioxyphenyl)propan-2-amine | 13674-05-0 | MMDA | COC1=C2OCOC2=CC(CC(C)N)=C1 |
262 | 1-戊基-3-(2-甲氧基苯乙酰基)吲哚 | 2-(2-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone | 864445-43-2 | JWH-250 | CCCCCN1C=C(C(=O)CC2=C(OC)C=CC=C2)C2=C1C=CC=C2 |
263 | 甲米雷司 | 4-Methyl-5-phenyl-4,5-dihydrooxazol-2-amine | 3568-94-3 | 4-Methylaminorex | CC1N=C(N)OC1C1=CC=CC=C1 |
264 | 3,4-亚甲二氧基甲基苯丙胺 | 1-(3,4-Methylenedioxyphenyl)-N-methylpropan-2-amine | 42542-10-9 | MDMA | CNC(C)CC1=CC=C2OCOC2=C1 |
265 | 3,4-亚甲二氧基甲卡西酮 | 1-(3,4-Methylenedioxyphenyl)-2-methylaminopropan-1-one | 186028-79-5 | Methylone | CNC(C)C(=O)C1=CC=C2OCOC2=C1 |
266 | 1-[3,4-(亚甲二氧基)苯基]-2-(N-吡咯烷基)-1-戊酮 | 1-(3,4-Methylenedioxyphenyl)-2-(1-pyrrolidinyl)pentan-1-one | 687603-66-3 | MDPV | CCCC(C(=O)C1=CC=C2OCOC2=C1)N1CCCC1 |
267 | 4-甲基乙卡西酮 | 1-(4-Methylphenyl)-2-ethylaminopropan-1-one | 1225617-18-4 | 4-MEC | CCNC(C)C(=O)C1=CC=C(C)C=C1 |
268 | 4-甲基甲卡西酮 | 1-(4-Methylphenyl)-2-methylaminopropan-1-one | 5650-44-2 | 4-MMC | CNC(C)C(=O)C1=CC=C(C)C=C1 |
269 | 4-甲硫基苯丙胺 | 1-(4-(Methylthio)phenyl)propan-2-amine | 14116-06-4 | 4-MTA | CSC1=CC=C(CC(C)N)C=C1 |
270 | N-羟基-3,4-亚甲二氧基苯丙胺 | N-(1-(3,4-Methylenedioxyphenyl)propan-2-yl)hydroxylamine | 74698-47-8 | N-hydroxy MDA |
CC(CC1=CC=C2OCOC2=C1)NO |
271 | 3,4-亚甲二氧基乙基苯丙胺 | N-Ethyl-1-(3,4-methylenedioxyphenyl)propan-2-amine | 82801-81-8 | MDEA | CCNC(C)CC1=CC=C2OCOC2=C1 |
272 | Δ3-己基四氢大麻酚 | 3-Hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | 117-51-1 | Parahexyl | CCCCCCC1=CC2=C(C3=C(CCC(C)C3)C(C)(C)O2)C(O)=C1 |
273 | 1-戊基-3-(1-萘甲酰基)吲哚 | Naphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone | 209414-07-3 | JWH-018 | CCCCCN1C=C(C(=O)C2=C3C=CC=CC3=CC=C2)C2=C1C=CC=C2 |
274 | 苯环利定 | 1-(1-Phenylcyclohexyl)piperidine | 77-10-1 | PPhencyclidine PCP |
C1=CC=C(C2(N3CCCCC3)CCCCC2)C=C1 |
275 | 芬美曲秦 | 3-Methyl-2-phenylmorpholine | 134-49-6 | Phenmetrazine | CC1NCCOC1C1=CC=CC=C1 |
276 | 4-甲氧基苯丙胺 | 1-(4-Methoxyphenyl)propan-2-amine | 64-13-1 | PMA | COC1=CC=C(CC(C)N)C=C1 |
277 | 赛洛新 | 3-(2-(Dimethylamino)ethyl)-1H-indol-4-ol | 520-53-6 | Psilocine | CN(C)CCC1=CNC2=CC=CC(O)=C12 |
278 | 赛洛西宾 | 3-(2-(Dimethylamino)ethyl)-1H-indol-4-yl dihydrogen phosphate | 520-52-5 | Psilocybine | CN(C)CCC1=CNC2=C1C(OP(=O)(O)O)=CC=C2 |
279 | 咯环利定 | 1-(1-Phenylcyclohexyl)pyrrolidine | 2201-39-0 | Rolicyclidine PCPy |
C1=CC=C(C2(N3CCCC3)CCCCC2)C=C1 |
280 | 替苯丙胺 | 1-(3,4-Methylenedioxyphenyl)propan-2-amine | 4764-17-4 | MDA | CC(N)CC1=CC=C2OCOC2=C1 |
281 | 替诺环定 | 1-(1-(Thiophen-2-yl)cyclohexyl)piperidine | 21500-98-1 | Tenocyclidine TCP |
C1=CSC(C2(N3CCCCC3)CCCCC2)=C1 |
282 | 四氢大麻酚(Δ3-四氢大麻酚、Δ4-四氢大麻酚、Δ5-四氢大麻酚、Δ8-四氢大麻酚、Δ10-四氢大麻酚、exo-四氢大麻酚) | 6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol 6,6,9-Trimethyl-3-pentyl-8,9,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol 6,6,9-Trimethyl-3-pentyl-6a,9,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol 6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol 6,6,9-Trimethyl-3-pentyl-6a,7,8,9-tetrahydro-6H-benzo[c]chromen-1-ol 6,6-Dimethyl-9-methylene-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol |
95720-01-7 59042-44-3 162678-94-6 5957-75-5 95543-62-7 27179-28-8 |
Tetrahydrocannabinol THC(Δ3-THC、Δ4-THC、Δ5-THC、Δ8-THC、Δ10-THC、exo-THC) |
CCCCCC1=CC(=C2C3=C(CC[C@H](C3)C)C(OC2=C1)(C)C)O CCCCCC1=CC(=C2[C@@H]3C[C@@H](CC=C3C(OC2=C1)(C)C)C)O CCCCCC1=CC(=C2[C@@H]3C[C@@H](C=C[C@H]3C(OC2=C1)(C)C)C)O CCCCCC1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C)O CCCCCC1=CC(=C2C3=C[C@@H](CC[C@H]3C(OC2=C1)(C)C)C)O CCCCCC1=CC(=C2[C@@H]3CC(=C)CC[C@H]3C(OC2=C1)(C)C)O |
283 | 3,4,5-三甲氧基苯丙胺 | 1-(3,4,5-Trimethoxyphenyl)propan-2-amine | 1082-88-8 | TMA | COC1=C(OC)C(OC)=CC(CC(C)N)=C1 |
284 | 阿米雷司 | 5-Phenyl-4,5-dihydrooxazol-2-amine | 2207-50-3 | Aminorex | NC1=NCC(C2=CC=CC=C2)O1 |
285 | N-苄基甲基苯丙胺 | N-Benzyl-N-methyl-1-phenylpropan-2-amine | 101-47-3 | Benzphetamine | CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2 |
286 | 丁巴比妥 | 5-Butyl-5-ethylbarbituric acid | 77-28-1 | Butobarbital | CCCCC1(CC)C(=O)NC(=O)NC1=O |
287 | 卡马西泮 | 7-Chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl dimethylcarbamate | 36104-80-0 | Camazepam | CN(C)C(=O)OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N(C)C1=O |
288 | 氯拉䓬酸 | 7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepine-3-carboxylic acid | 23887-31-2 | Clorazepate | O=C(O)C1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2NC1=O |
289 | 环己巴比妥 | 5-(1-Cyclohexen-1-yl)-5-ethylbarbituric acid | 52-31-3 | Cyclobarbital | CCC1(C2=CCCCC2)C(=O)NC(=O)NC1=O |
290 | 乙氯维诺 | 1-Chloro-3-ethylpent-1-en-4-yn-3-ol | 113-18-8 | Ethchlorvynol | C#CC(O)(/C=C/Cl)CC |
291 | 炔己蚁胺 | 1-Ethynylcyclohexyl carbamate | 126-52-3 | Ethinamate | C#CC1(OC(N)=O)CCCCC1 |
292 | 乙基苯丙胺 | N-Ethyl-1-phenylpropan-2-amine | 457-87-4 | Ethylamphetamine | CCNC(C)CC1=CC=CC=C1 |
293 | 芬坎法明 | N-Ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine | 1209-98-9 | Fencamfamin | CCNC1C2CCC(C2)C1C1=CC=CC=C1 |
294 | 芬普雷司 | 3-((1-Phenylpropan-2-yl)amino)propanenitrile | 16397-28-7 | Fenproporex | CC(CC1=CC=CC=C1)NCCC#N |
295 | 呋芬雷司 | N-(Furan-2-ylmethyl)-N-methyl-1-phenylpropan-2-amine | 3776-93-0 | Furfennorex | CC(CC1=CC=CC=C1)N(C)CC1=CC=CO1 |
296 | 哈拉西泮 | 7-Chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one | 23092-17-3 | Halazepam | O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1CC(F)(F)F |
297 | 凯他唑仑 | 11-Chloro-2,8-dimethyl-12b-phenyl-8,12b-dihydro-4H-benzo[f][1,3]oxazino[3,2-d][1,4]diazepine-4,7(6H)-dione | 27223-35-4 | Ketazolam | CC1=CC(=O)N2CC(=O)N(C)C3=CC=C(Cl)C=C3C2(C2=CC=CC=C2)O1 |
298 | 利非他明 | N,N-Dimethyl-1,2-diphenylethanamine | 7262-75-1 | Lefetamine SPA |
CN(C)[C@H](CC1=CC=CC=C1)C1=CC=CC=C1 |
299 | 美芬雷司 | 3-Chloro-N-(1-phenylpropan-2-yl)propan-1-amine | 17243-57-1 | Mefenorex | CC(CC1=CC=CC=C1)NCCCCl |
300 | 美索卡 | N-Phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate | 34262-84-5 | Mesocarb | CC(CC1=CC=CC=C1)[N+]1=NOC(/N=C(\[O-])NC2=CC=CC=C2)=C1 |
301 | 甲乙哌酮 | 3,3-Diethyl-5-methylpiperidine-2,4-dione | 125-64-4 | Methyprylon | CCC1(CC)C(=O)NCC(C)C1=O |
302 | 匹莫林 | 2-Amino-5-phenyloxazol-4(5H)-one | 2152-34-3 | Pemoline | NC1=NC(=O)C(C2=CC=CC=C2)O1 |
303 | 丙己君 | 1-Cyclohexyl-N-methylpropan-2-amine | 101-40-6 | Propylhexedrine | CNC(C)CC1CCCCC1 |
304 | 1-(4-甲基苯基)-2-(N-吡咯烷基)-1-戊酮 | 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)pentan-1-one | 3563-49-3 | Pyrovalerone 4-MPVP> |
CCCC(C(=O)C1=CC=C(C)C=C1)N1CCCC1 |
305 | 乙烯比妥 | 5-(1-Methylbutyl)-5-vinylbarbituric acid | 2430-49-1 | Vinylbital | C=CC1(C(C)CCC)C(=O)NC(=O)NC1=O |
306 | 醋托啡 | Acetorphine | 25333-77-1 | CCC[C@@](C)(O)[C@H]1C[C@]23C=C[C@]1(OC)[C@@H]1COC4=C5C(=CC=C4OC(C)=O)C[C@H]2N(C)CC[C@]513 |
|
307 | 乙酰阿法甲基芬太尼 | N-Phenyl-N-(1-(1-phenylpropan-2-yl)piperidin-4-yl)acetamide | 101860-00-8 | Acetyl-alpha-methylfentanyl | CC(=O)N(C1=CC=CC=C1)C1CCN(C(C)CC2=CC=CC=C2)CC1 |
308 | 醋氢可待因 | Acetyldihydrocodeine | 3861-72-1 | COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](OC(C)=O)[C@@H]5OC1=C2[C@@]54CCN3C |
|
309 | 醋美沙朵 | Acetylmethadol | 509-74-0 | CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
310 | 烯丙罗定 | Allylprodine | 25384-17-2 | C=CCC1CN(C)CCC1(OC(=O)CC)C1=CC=CC=C1 |
|
311 | 阿醋美沙朵 | Alphacetylmethadol | 17199-58-5 | CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
312 | 阿法美罗定 | Alphameprodine | 468-51-9 | CCC(=O)O[C@]1(C2=CC=CC=C2)CCN(C)C[C@H]1CC |
|
313 | 阿法美沙朵 | Alphamethadol | 17199-54-1 | CC[C@@H](O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
314 | 阿法甲基芬太尼 | N-Phenyl-N-(1-(1-phenylpropan-2-yl)piperidin-4-yl)propionamide | 79704-88-4 | Alpha-methylfentanyl | CCC(=O)N(C1=CC=CC=C1)C1CCN(CC(O)C2=CC=CC=C2)CC1 |
315 | 阿法甲基硫代芬太尼 | N-Phenyl-N-(1-(1-(thiophen-2-yl)propan-2-yl)piperidin-4-yl)propionamide | 103963-66-2 | Alpha-methylthiofentanyl | CCC(=O)N(C1=CC=CC=C1)C1CCN(C(C)CC2=CC=CS2)CC1 |
316 | 苄替啶 | Benzethidine | 3691-78-9 | CCOC(=O)C1(C2=CC=CC=C2)CCN(CCOCC2=CC=CC=C2)CC1 |
|
317 | 苄吗啡 | Benzylmorphine | 36418-34-5 | CN1CC[C@]23C4=C5O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1CC4=CC=C5OCC1=CC=CC=C1 |
|
318 | 倍醋美沙朵 | Betacetylmethadol | 17199-59-6 | CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
319 | 倍他羟基-3-甲基芬太尼 | N-(1-(2-Hydroxy-2-phenylethyl)piperidin-4-yl)-N-phenylpropionamide | 78995-14-9 | Beta-hydroxy-3-methylfentanyl | CCC(=O)N(C1=CC=CC=C1)C1CCN(CC(O)C2=CC=CC=C2)CC1C |
320 | 倍他羟基芬太尼 | N-(1-(2-Hydroxy-2-phenylethyl)-3-methylpiperidin-4-yl)-N-phenylpropionamide | 78995-10-5 | Beta-hydroxyfentanyl | CCC(=O)N(C1=CC=CC=C1)C1CCN(CC(O)C2=CC=CC=C2)CC1 |
321 | 倍他美罗定 | Betameprodine | 468-50-8 | CCC(=O)O[C@]1(C2=CC=CC=C2)CCN(C)C[C@H]1CC |
|
322 | 倍他美沙朵 | Betamethadol | 17199-55-2 | CC[C@H](O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
323 | 倍他罗定 | Betaprodine | 468-59-7 | CCC(=O)O[C@]1(C2=CC=CC=C2)CCN(C)C[C@H]1C |
|
324 | 贝齐米特 | Bezitramide | 15301-48-1 | CCC(=O)N1C(=O)N(C2CCN(CCC(C#N)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C2=C1C=CC=C2 |
|
325 | 大麻和大麻树脂与大麻浸膏和酊 | Cannabis and Cannabis Resin and Extracts and Tinctures of Cannabis | 8063-14-7 | CCCCCC1=CC2=C(C(O)=C1)[C@@H]1C=C(C)CC[C@H]1C(C)(C)O2 |
|
326 | 氯尼他秦 | 2-(2-(4-Chlorobenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethanamine | 3861-76-5 | Clonitazene | CCN(CC)CCN1C(CC2=CC=C(Cl)C=C2)=NC2=CC([N+](=O)[O-])=CC=C21 |
327 | 古柯叶 | Coca Leaf | |||
328 | 可卡因 | Cocaine | 50-36-2 | COC(=O)[C@H]1[C@@H](OC(=O)C2=CC=CC=C2)CC23[C@H](CC[C@H]12)N3C |
|
329 | 可多克辛 | Codoxime | 7125-76-0 | COC1=CC=C2C[C@@H]3[C@@H]4CC/C(=N\OCC(=O)O)[C@@H]5OC1=C2[C@@]54CCN3C |
|
330 | 地索吗啡 | Desomorphine | 427-00-9 | CN1CC[C@]23C4=C5O[C@H]2CCC[C@H]3[C@H]1CC4=CC=C5O |
|
331 | 右吗拉胺 | Dextromoramide | 357-56-2 | C[C@H](CN1CCOCC1)C(C(=O)N1CCCC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
332 | 右丙氧芬* | Dextropropoxyphene | 469-62-5 | CCC(=O)O[C@](CC1=CC=CC=C1)(C1=CC=CC=C1)[C@H](C)CN(C)C |
|
333 | 地恩丙胺 | Diampromide | 552-25-0 | CCC(=O)N(CC(C)N(C)CCC1=CC=CC=C1)C1=CC=CC=C1 |
|
334 | 二乙噻丁 | N,N-Diethyl-4,4-di(thiophen-2-yl)but-3-en-2-amine | 86-14-6 | Diethylthiambutene | CCN(CC)C(C)C=C(C1=CC=CS1)C1=CC=CS1 |
335 | 双氢吗啡 | Dihydromorphine | 509-60-4 | CN1CC[C@]23C4=C5O[C@H]2[C@@H](O)CC[C@H]3[C@H]1CC4=CC=C5O |
|
336 | 地美沙朵 | Dimenoxadol | 509-78-4 | CCOC(C(=O)OCCN(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
337 | 地美庚醇 | 6-(Dimethylamino)-4,4-diphenylheptan-3-ol | 545-90-4 | Dimepheptanol | CCC(O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
338 | 二甲噻丁 | N,N-Dimethyl-4,4-di(thiophen-2-yl)but-3-en-2-amine | 524-84-5 | Dimethylthiambutene | CC(C=C(C1=CC=CS1)C1=CC=CS1)N(C)C |
339 | 吗苯丁酯 | Ethyl 4-(morpholin-4-yl)-2,2-diphenylbutanoate | 467-86-7 | Dioxaphetyl Butyrate | CCOC(=O)C(CCN1CCOCC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
340 | 地匹哌酮 | Dipipanone | 467-83-4 | CCC(=O)C(CC(C)N1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
341 | 芽子碱,及其易转化为芽子碱和可卡因的衍生物 | Ecgonine, and derivatives which are convertible to ecgonine and cocaine | 481-37-8 | CN1[C@H]2CC[C@@H]3C(C(=O)O)[C@@H](O)CC231 |
|
342 | 乙甲噻丁 | N-Ethyl-N-methyl-4,4-di(thiophen-2-yl)but-3-en-2-amine | 441-61-2 | Ethylmethylthiambutene | CCN(C)C(C)C=C(C1=CC=CS1)C1=CC=CS1 |
343 | 依托尼秦 | 2-(2-(4-Ethoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethanamine | 911-65-9 | Etonitazene | CCOC1=CC=C(CC2=NC3=CC([N+](=O)[O-])=CC=C3N2CCN(CC)CC)C=C1 |
344 | 埃托啡 | Etorphine | 14521-96-1 | CCCC(C)(O)[C@H]1C[C@]23C=C[C@]1(OC)[C@@H]1COC4=C5C(=CC=C4O)C[C@H]2N(C)CC[C@]513 |
|
345 | 依托利定 | Etoxeridine | 469-82-9 | CCOC(=O)C1(C2=CC=CC=C2)CCN(CCOCCO)CC1 |
|
346 | 呋替啶 | Furethidine | 2385-81-1 | CCOC(=O)C1(C2=CC=CC=C2)CCN(CCOCC2CCCO2)CC1 |
|
347 | 海洛因 | Heroin | 561-27-3 | CC(=O)OC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](OC(C)=O)[C@@H]5OC1=C2[C@@]54CCN3C |
|
348 | 氢吗啡醇 | Hydromorphinol | 2183-56-4 | CN1CC[C@]23C4=C5O[C@H]2[C@@H](O)CC[C@@]3(O)[C@H]1CC4=CC=C5O |
|
349 | 羟哌替啶 | Hydroxypethidine | 468-56-4 | CCOC(=O)C1(C2=CC=CC(O)=C2)CCN(C)CC1 |
|
350 | 异美沙酮 | Isomethadone | 466-40-0 | CCC(=O)C(C1=CC=CC=C1)(C1=CC=CC=C1)C(C)CN(C)C |
|
351 | 凯托米酮 | Ketobemidone | 469-79-4 | CCC(=O)C1(C2=CC=CC(O)=C2)CCN(C)CC1 |
|
352 | 左美沙芬 | Levomethorphan | 125-70-2 | COC1=CC2=C(C=C1)C[C@@H]1[C@@H]3CCCC[C@]23CCN1C |
|
353 | 左吗拉胺 | Levomoramide | 5666-11-5 | C[C@@H](CN1CCOCC1)C(C(=O)N1CCCC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
354 | 左芬啡烷 | Levophenacylmorphan | 10061-32-2 | O=C(CN1CC[C@]23CCCC[C@H]2[C@H]1CC1=CC=C(O)C=C13)C1=CC=CC=C1 |
|
355 | 美他佐辛 | Metazocine | 3734-52-9 | CC1C2CC3=CC=C(O)C=C3C1(C)CCN2C |
|
356 | 4-二甲氨基-2,2-二苯基戊腈(美沙酮中间体) | 4-(Dimethylamino)-2,2-diphenylpentanenitrile | 125-79-1 | Methadone Intermediate | CC(CC(C#N)(C1=CC=CC=C1)C1=CC=CC=C1)N(C)C |
357 | 甲地索啡 | Methyldesorphine | 16008-36-9 | CC1=CC[C@H]2[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3C)[C@H]1O5 |
|
358 | 甲二氢吗啡 | Methyldihydromorphine | 509-56-8 | CN1CC[C@]23C4=C5O[C@H]2[C@@](C)(O)CC[C@H]3[C@H]1CC4=CC=C5O |
|
359 | 3-甲基芬太尼 | N-(3-Methyl-1-phenethylpiperidin-4-yl)-N-phenylpropionamide | 42045-86-3 | 3-Methylfentanyl | CCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1C |
360 | 3-甲基硫代芬太尼 | N-(3-Methyl-1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropionamide | 86052-04-2 | 3-Methylthiofentanyl | CCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CS2)CC1C |
361 | 1-甲基-4-苯基-4-哌啶丙酸酯 | 1-Methyl-4-phenylpiperidin-4-yl propionate | 13147-09-6 | MPPP | CCC(=O)OC1(C2=CC=CC=C2)CCN(C)CC1 |
362 | 美托酮 | Metopon | 143-52-2 | CN1CC[C@]23C4=C5O[C@@]2(C)C(=O)CC[C@H]3[C@H]1CC4=CC=C5O |
|
363 | 3-甲基-4-(吗啉-4-基)-2,2-二苯基丁酸(吗拉胺中间体) | 3-Methyl-4-(morpholin-4-yl)-2,2-diphenylbutanoic acid | 3626-55-9 | Moramide Intermediate | CC(CN1CCOCC1)C(C(=O)O)(C1=CC=CC=C1)C1=CC=CC=C1 |
364 | 吗哌利定 | Morpheridine | 469-81-8 | CCOC(=O)C1(C2=CC=CC=C2)CCN(CCN2CCOCC2)CC1 |
|
365 | 吗啡甲溴化物,及其他五价氮吗啡衍生物(特别是吗啡-N-氧化物的衍生物,例如可待因-N-氧化物) | Morphine Methobromide, and other pentavalent nitrogen morphine derivatives, including in particular the morphine-N-oxide derivatives, one of which is codeine-N-oxide | 125-23-5 | [Br-].C[N+]1(C)CC[C@]23C4=C5O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1CC4=CC=C5O |
|
366 | 吗啡-N-氧化物 | Morphine-N-oxide | 639-46-3 | C[N+]1([O-])CC[C@]23C4=C5O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1CC4=CC=C5O |
|
367 | 麦罗啡 | 3-O-Benzyl-6-O-myristoylmorphine | 467-18-5 | Myrophine | CCCCCCCCCCCCCC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=CC=C(OCC5=CC=CC=C5)C5=C4[C@@]2(CCN3C)[C@H]1O5 |
368 | 尼可待因 | Nicocodine | 3688-66-2 | CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@@H](O)[C@@H]5OC1=C2[C@]45CCN3C |
|
369 | 尼二氢可待因 | Nicodicodine | 808-24-2 | COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](OC(=O)C5=CC=CN=C5)[C@@H]5OC1=C2[C@@]54CCN3C |
|
370 | 尼可吗啡 | Nicomorphine | 639-48-5 | CN1CC[C@]23C4=C5O[C@H]2[C@@H](OC(=O)C2=CC=CN=C2)C=C[C@H]3[C@H]1CC4=CC=C5OC(=O)C1=CN=CC=C1 |
|
371 | 诺美沙朵 | Noracymethadol | 1477-39-0 | CCC(OC(C)=O)C(CC(C)NC)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
372 | 去甲可待因 | Norcodeine | 467-15-2 | COC1=CC=C2C[C@H]3NCC[C@]45C2=C1O[C@H]4[C@@H](O)C=C[C@@H]35 |
|
373 | 去甲左啡诺 | Norlevorphanol | 1531-12-0 | OC1=CC2=C(C=C1)C[C@H]1NCC[C@@]23CCCC[C@@H]13 |
|
374 | 去甲美沙酮 | Normethadone | 467-85-6 | CCC(=O)C(CCN(C)C)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
375 | 去甲吗啡 | Normorphine | 466-97-7 | OC1=CC=C2C[C@H]3NCC[C@]45C2=C1O[C@H]4[C@@H](O)C=C[C@@H]35 |
|
376 | 诺匹哌酮 | 4,4-Diphenyl-6-(piperidin-1-yl)hexan-3-one | 561-48-8 | Norpipanone | CCC(=O)C(CCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
377 | 奥列巴文 | Oripavine | 467-04-9 | COC1=CC=C2[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3C)[C@H]1O5 |
|
378 | 对氟芬太尼 | N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide | 90736-23-5 | Para-fluorofentanyl | CCC(=O)N(C1=CC=C(F)C=C1)C1CCN(CCC2=CC=CC=C2)CC1 |
379 | 4-氰基-1-甲基-4-苯基哌啶(哌替啶中间体A) | 1-Methyl-4-phenylpiperidine-4-carbonitrile | 3627-62-1 | Pethidine Intermediate A | CN1CCC(C#N)(C2=CC=CC=C2)CC1 |
380 | 4-苯基哌啶-4-甲酸乙酯(哌替啶中间体B) | Ethyl 4-phenylpiperidine-4-carboxylate | 77-17-8 | Pethidine Intermediate B | CCOC(=O)C1(C2=CC=CC=C2)CCNCC1 |
381 | 1-甲基-4-苯基哌啶-4-甲酸(哌替啶中间体C) | 1-Methyl-4-phenylpiperidine-4-carboxylic acid | 3627-48-3 | Pethidine Intermediate C | CN1CCC(C(=O)O)(C2=CC=CC=C2)CC1 |
382 | 苯吗庚酮 | Phenadoxone | 467-84-5 | CCC(=O)C(CC(C)N1CCOCC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
383 | 非那丙胺 | N-Phenyl-N-(1-(piperidin-1-yl)propan-2-yl)propionamide | 129-83-9 | Phenampromide | CCC(=O)N(C1=CC=CC=C1)C(C)CN1CCCCC1 |
384 | 非那佐辛 | Phenazocine | 127-35-5 | CC1C2CC3=CC=C(O)C=C3C1(C)CCN2CCC1=CC=CC=C1 |
|
385 | 1-苯乙基-4-苯基-4-哌啶乙酸酯 | 1-Phenethyl-4-phenylpiperidin-4-yl acetate | 64-52-8 | PEPAP | CC(=O)OC1(C2=CC=CC=C2)CCN(CCC2=CC=CC=C2)CC1 |
386 | 非诺啡烷 | Phenomorphan | 468-07-5 | OC1=CC=C2C[C@@H]3[C@@H]4CCCC[C@]4(CCN3CCC3=CC=CC=C3)C2=C1 |
|
387 | 苯哌利定 | Phenoperidine | 562-26-5 | CCOC(=O)C1(C2=CC=CC=C2)CCN(CCC(O)C2=CC=CC=C2)CC1 |
|
388 | 匹米诺定 | Piminodine | 13495-09-5 | CCOC(=O)C1(C2=CC=CC=C2)CCN(CCCNC2=CC=CC=C2)CC1 |
|
389 | 哌腈米特 | Piritramide | 302-41-0 | N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
390 | 普罗庚嗪 | Proheptazine | 77-14-5 | CCC(=O)OC1(C2=CC=CC=C2)CCCN(C)CC1C |
|
391 | 丙哌利定 | Properidine | 561-76-2 | CC(C)OC(=O)C1(C2=CC=CC=C2)CCN(C)CC1 |
|
392 | 丙吡兰 | N-(1-(Piperidin-1-yl)propan-2-yl)-N-(pyridin-2-yl)propionamide | 15686-91-6 | Propiram | CCC(=O)N(C1=NC=CC=C1)C(C)CN1CCCCC1 |
393 | 消旋吗拉胺 | Racemoramide | 545-59-5 | CC(CN1CCOCC1)C(C(=O)N1CCCC1)(C1=CC=CC=C1)C1=CC=CC=C1 |
|
394 | 醋氢可酮 | Thebacon | 466-90-0 | COC1=CC=C2C[C@@H]3[C@@H]4CC=C(OC(C)=O)[C@@H]5OC1=C2[C@@]54CCN3C |
|
395 | 硫代芬太尼 | N-Phenyl-N-(1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)propionamide | 1165-22-6 | Thiofentanyl | CCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CS2)CC1 |
396 | 三甲利定 | Trimeperidine | 64-39-1 | CCC(=O)OC1(C2=CC=CC=C2)C[C@H](C)N(C)C[C@H]1C |
芬太尼类物质
“芬太尼类物质”是指化学结构与芬太尼(N-[1-(2-苯乙基)-4-哌啶基]-N-苯基丙酰胺)相比,符合以下一个或多个条件的物质:
(一)使用其他酰基替代丙酰基;
(二)使用任何取代或未取代的单环芳香基团替代与氮原子直接相连的苯基;
(三)哌啶环上存在烷基、烯基、烷氧基、酯基、醚基、羟基、卤素、卤代烷基、氨基及硝基等取代基;
(四)使用其他任意基团(氢原子除外)替代苯乙基。
已列入《麻醉药品品种目录》的芬太尼类物质按《麻醉药品品种目录》予以管制。
合成大麻素类物质
“合成大麻素类物质”是指具有下列化学结构通式的物质:
R1 代表取代或未取代的 C3-C8 烃基;取代或未取代的含有 1-3 个杂原子的杂环基;取代或未取代的含有 1-3 个杂原子的杂环基取代的甲基或乙基。
R2 代表氢或甲基或无任何原子。
R3 代表取代或未取代的 C6-C10 的芳基;取代或未取代的 C3-C10 的烃基;取代或未取代的含有 1-3 个杂原子的杂环基;取代或未取代的含有 1-3 个杂原子的杂环基取代的甲基或乙基。
R4 代表氢;取代或未取代的苯基;取代或未取代的苯甲基。
R5 代表取代或未取代的 C3-C10 的烃基。
X 代表 N 或 C。
Y 代表 N 或 CH。
Z 代表 O 或 NH 或无任何原子。
尼秦类物质
“尼秦类物质”是指化学结构与依托尼秦(2-(2-(4-乙氧基苄基)-5-硝基-1H-苯并咪唑-1-基)-N,N-二乙基-1-乙胺)相比,符合以下一个或多个条件的物质:
(一)使用取代或未取代的 1H-苯并咪唑基替代 5-硝基-1H-苯并咪唑基;
(二)使用取代或未取代的 C1-C2 烃基替代 1H-苯并咪唑基与苯基之间的亚甲基;
(三)使用取代或未取代的芳香基团替代 4-乙氧基苯基;
(四)使用取代或未取代的氨基替代 N,N-二乙基氨基。
注:1. 上述品种包含其可能存在的盐类、立体异构体及其盐类(另有规定的除外)。2. 上述 305-396 品种还包括其酯和醚,以及其酯和醚可能存在的盐类、立体异构体及其盐类(另有规定的除外)。
本文章参考:
国家药监局 公安部 国家卫生健康委关于发布药用类麻醉药品和精神药品目录的公告(2025 年第 55 号)
三部门联合发布最新版《非药用类麻醉药品和精神药品目录》